Nomad Foods Limited (NOMD) 6-K 4 Nov 21 Nomad Foods Reports Third Quarter 2021 Financial Results Financial data

Cover

Cover	9 Months Ended
	Sep. 30, 2021
Cover [Abstract]
Document Type	6-K
Amendment Flag	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Registrant Name	Nomad Foods Ltd.
Entity Central Index Key	0001651717
Current Fiscal Year End Date	--12-31

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Interim Statements of Financial Position - EUR (€) € in Millions	Sep. 30, 2021	Dec. 31, 2020
Non-current assets
Goodwill	€ 2,256	€ 1,902.5
Intangibles	2,274.2	2,155.7
Property, plant and equipment	506.3	422.2
Other non-current assets	7.5	1.1
Derivative financial instruments	0	17.2
Deferred tax assets	126.2	113.5
Total non-current assets	5,170.2	4,612.2
Current assets
Cash and cash equivalents	211.6	393.2
Inventories	427.5	344.3
Trade and other receivables	242.2	185
Indemnification assets	9.9	15.4
Short-term investments	0	25
Derivative financial instruments	13.2	5.5
Total current assets	904.4	968.4
Total assets	6,074.6	5,580.6
Current liabilities
Trade and other payables	608.4	647.2
Current tax payable	229.5	166.2
Provisions	37.4	45.7
Loans and borrowings	27.4	22.5
Derivative financial instruments	6.5	35.5
Total current liabilities	909.2	917.1
Non-current liabilities
Loans and borrowings	2,179.6	1,736.3
Employee benefits	249.2	276.2
Other non-current liabilities	1.9	2.2
Provisions	2.9	6.1
Derivative financial instruments	44.6	89.5
Deferred tax liabilities	374.4	427.1
Total non-current liabilities	2,852.6	2,537.4
Total liabilities	3,761.8	3,454.5
Net assets	2,312.8	2,126.1
Equity attributable to equity holders
Share capital and capital reserve	1,690.2	1,620.5
Share based compensation reserve	3.8	8.3
Founder Preferred Shares Dividend reserve	166	245.5
Translation reserve	92.1	84.7
Other reserves	5.9	(24.5)
Retained earnings	354.8	191.6
Equity attributable to owners of parent	€ 2,312.8	€ 2,126.1

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Interim Statements of Profit or Loss - EUR (€) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Profit or loss [abstract]
Revenue	€ 599.4	€ 576.3	€ 1,902.6	€ 1,858.2
Cost of sales	(431.8)	(401.1)	(1,338.6)	(1,302.8)
Gross profit	167.6	175.2	564	555.4
Other operating expenses	(80.5)	(85.7)	(257.6)	(268.8)
Exceptional items	(6.5)	(2.5)	(21.6)	(27.3)
Operating profit	80.6	87	284.8	259.3
Finance income	10.4	1.1	0	6.3
Finance costs	(25.4)	(16.8)	(90.4)	(50.5)
Net financing costs	(15)	(15.7)	(90.4)	(44.2)
Profit before tax	65.6	71.3	194.4	215.1
Taxation	(13.9)	(14.9)	(42.2)	(48.7)
Profit for the period	51.7	56.4	152.2	166.4
Equity owners of the parent	51.7	56.4	152.2	166.5
Non-controlling interests	€ 0	€ 0	€ 0	€ (0.1)
Earnings per share
Basic and diluted earnings per share (in euros per share)	€ 0.29	€ 0.29

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Interim Statements of Comprehensive Income/(Loss) - EUR (€) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of comprehensive income [abstract]
Profit for the period	€ 51.7	€ 56.4	€ 152.2	€ 166.4
Other comprehensive income/(loss):
Actuarial gains/(losses) on defined benefit pension plans	4.7	(13.6)	32.3	(22.1)
Taxation (charge)/credit on measurement of defined benefit pension plans	(1.8)	4.4	(10.2)	7.1
Items not reclassified to the Statement of Profit or Loss	2.9	(9.2)	22.1	(15)
(Loss)/gain on investment in foreign subsidiary, net of hedge	(0.5)	(0.4)	5.8	(10.2)
Effective portion of changes in fair value of cash flow hedges and cost of hedging	24.4	(14.7)	39.8	3.2
Taxation (charge)/credit relating to components of other comprehensive income	(5.8)	4.5	(10.7)	2.1
Items that may be subsequently reclassified to the Statement of Profit or Loss	18.1	(10.6)	34.9	(4.9)
Other comprehensive income/(loss) for the period, net of tax	21	(19.8)	57	(19.9)
Total comprehensive income for the period	72.7	36.6	209.2	146.5
Equity owners of the parent	72.7	36.6	209.2	146.6
Non-controlling interests	€ 0	€ 0	€ 0	€ (0.1)

Unaudited Condensed Consolida_4

Unaudited Condensed Consolidated Interim Statements of Changes in Equity - EUR (€) € in Millions	Total	Share capital and capital reserve	Share based compensation reserve	Founder preferred shares dividend reserve	Translation reserve	Other reserves*	Retained earnings	Total equity	Non-controlling interests
Equity attributable to owners of parent		€ 2,095.4	€ 22.6	€ 370.1	€ 94.8	€ (13.2)	€ (11.8)	€ 2,557.9
Equity	€ 2,556.7								€ (1.2)
Equity attributable to owners, beginning balance at Dec. 31, 2019		2,095.4	22.6	370.1	94.8	(13.2)	(11.8)	2,557.9
Equity at Dec. 31, 2019	2,556.7								(1.2)
Equity owners of the parent	166.5						166.5	166.5
Profit for the period	166.4								(0.1)
Other comprehensive income for the period	(19.9)				(9.3)	4.4	(15)	(19.9)
Total comprehensive income for the period	146.6				(9.3)	4.4	151.5	146.6
Comprehensive income	146.5								(0.1)
Founder Preferred Shares Annual Dividend Amount		124.6		(124.6)
Issue of ordinary shares	0.3	8.2	(7.9)					0.3
Share based payment charge	5.3		5.3					5.3
Reduction of issued capital	(479.8)	(479.8)						(479.8)
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity	0	0.7	(0.7)					0
Reclassification of awards for settlement of tax liabilities	(14.2)		(14.2)					(14.2)
Total transactions with owners, recognized directly in equity	(489.4)	(346.3)	(17.5)	(124.6)	0	0	(2.3)	(490.7)	1.3
Equity attributable to owners, ending balance at Sep. 30, 2020		1,749.1	5.1	245.5	85.5	(8.8)	137.4	2,213.8
Equity at Sep. 30, 2020	2,213.8								0
Non controlling interest through acquisition of subsidiary	(1)						(2.3)	(2.3)	1.3
Equity owners of the parent	166.5						166.5	166.5
Profit for the period	166.4								(0.1)
Other comprehensive income for the period	(19.9)				(9.3)	4.4	(15)	(19.9)
Equity owners of the parent	146.6				(9.3)	4.4	151.5	146.6
Comprehensive income	146.5								(0.1)
Founder Preferred Shares Annual Dividend Amount		124.6		(124.6)
Share based payment charge	5.3		5.3					5.3
Issue of ordinary shares	0.3	8.2	(7.9)					0.3
Repurchase of ordinary shares	479.8	479.8						479.8
Reclassification of awards for settlement of tax liabilities	(14.2)		(14.2)					(14.2)
Total transactions with owners, recognized directly in equity	(489.4)	(346.3)	(17.5)	(124.6)	0	0	(2.3)	(490.7)	1.3
Equity attributable to owners of parent		1,749.1	5.1	245.5	85.5	(8.8)	137.4	2,213.8
Equity	2,213.8								€ 0
Equity attributable to owners of the parent (restated)					86.3	(26.1)
Equity attributable to owners of parent	2,126.1	1,620.5	8.3	245.5	84.7	(24.5)	191.6	2,126.1
Equity attributable to owners of the parent (restated)					86.3	(26.1)
Equity attributable to owners, beginning balance at Dec. 31, 2020	2,126.1	1,620.5	8.3	245.5	84.7	(24.5)	191.6	2,126.1
Equity owners of the parent	152.2						152.2	152.2
Profit for the period	152.2
Other comprehensive income for the period	57				5.8	29.1	22.1	57
Total comprehensive income for the period	209.2	0	0	0	5.8	29.1	174.3	209.2
Deferred hedging losses and costs of hedging transferred to the carrying value of inventory						2.9		2.9
Comprehensive income	209.2
Founder Preferred Shares Annual Dividend Amount		79.5		(79.5)				0
Issue of ordinary shares		0.1	(0.1)					0
Share based payment charge			1.8					1.8
Reduction of issued capital		(10.5)						(10.5)
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity		0.6	(0.6)
Reclassification of awards for settlement of tax liabilities		0	(5.6)				(11.1)	(16.7)
Total transactions with owners, recognized directly in equity		69.7	(4.5)	(79.5)	0	0	(11.1)	(25.4)
Equity attributable to owners, ending balance at Sep. 30, 2021	2,312.8	1,690.2	3.8	166	92.1	5.9	354.8	2,312.8
Fair value gain (loss) that would have been recognised in profit or loss or other comprehensive income if financial assets had not been reclassified as measured at amortised cost, initial application of IFRS 9					1.6	(1.6)
Equity owners of the parent	152.2						152.2	152.2
Profit for the period	152.2
Other comprehensive income for the period	57				5.8	29.1	22.1	57
Equity owners of the parent	209.2	0	0	0	5.8	29.1	174.3	209.2
Comprehensive income	209.2
Founder Preferred Shares Annual Dividend Amount		79.5		(79.5)				0
Share based payment charge			1.8					1.8
Issue of ordinary shares		0.1	(0.1)					0
Repurchase of ordinary shares		10.5						10.5
Reclassification of awards for settlement of tax liabilities		0	(5.6)				(11.1)	(16.7)
Total transactions with owners, recognized directly in equity		69.7	(4.5)	(79.5)	0	0	(11.1)	(25.4)
Equity attributable to owners of parent	€ 2,312.8	€ 1,690.2	€ 3.8	€ 166	€ 92.1	€ 5.9	€ 354.8	€ 2,312.8

Unaudited Condensed Consolida_5

Unaudited Condensed Consolidated Interim Statements of Cash Flows € in Millions	9 Months Ended
	Sep. 30, 2021EUR (€)	Sep. 30, 2020EUR (€)
Cash flows from operating activities
Profit for the period	€ 152.2	€ 166.4
Adjustments for:
Exceptional items	21.6	27.3
Non-cash fair value purchase price adjustment of inventory	2.3	0
Share based payments expense	1.8	5.3
Depreciation and amortization	50.7	51.6
(Gain)/loss on disposal of property, plant and equipment	(0.2)	0.1
Net finance costs	90.4	44.2
Taxation	42.2	48.7
Operating cash flow before changes in working capital, provisions and exceptional items	361	343.6
Increase in inventories	(39.5)	(43.7)
Decrease in trade and other receivables	7.9	12.1
(Decrease)/increase in trade and other payables	(82.4)	52.5
Increase in employee benefits and other provisions	0.7	1.9
Cash generated from operations before tax and exceptional items	247.7	366.4
Cash flows relating to exceptional items	(23.2)	(3.3)
Tax paid	(62.9)	(41.8)
Net cash generated from operating activities	161.6	321.3
Cash flows from investing activities
Purchase of subsidiaries, net of cash acquired	(597.3)	(1)
Purchase of property, plant and equipment and intangibles	(50.7)	(37.3)
Redemption of investments	15.5	25.2
Cash used in investing activities	(632.5)	(13.1)
Cash flows provided by/(used in) financing activities
Proceeds from issuance of ordinary shares	0	0.6
Repurchase of ordinary shares	(10.5)	(479.8)
Issuance of new loan principal	800	0
Repayment of loan principal	(408.7)	(11.7)
Payments related to shares withheld for taxes	22.5	18.5
Payment of lease liabilities	(14)	(16)
Payment of financing fees	(17.6)	0
Interest paid	(31.3)	(34.4)
Interest received	0	0.6
Other financing cash flows	(2.3)	(4.5)
Net cash provided by/(used in) financing activities	293.1	(563.7)
Net decrease in cash and cash equivalents	(177.8)	(255.5)
Cash and cash equivalents at beginning of period	211.6
Cash and cash equivalents at beginning of period	393.2	824.8
Effect of exchange rate fluctuations	6.9	(17)
Cash and cash equivalents at end of period	€ 211.6	€ 552.3

Cash and cash equivalents

Cash and cash equivalents	9 Months Ended
	Sep. 30, 2021
Subclassifications of assets, liabilities and equities [abstract]
Cash and cash equivalents	Cash and cash equivalents September 30, 2021 December 31, 2020 €m €m Cash and cash equivalents 211.2 393.1 Restricted cash 0.4 0.1 Cash and cash equivalents 211.6 393.2 Bank overdraft — (10.7) Cash and cash equivalents per Statement of Cash Flows 211.6 382.5

Founder Preferred Shares Divide

Founder Preferred Shares Dividend Reserve	9 Months Ended
	Sep. 30, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Founder Preferred Shares Dividend Reserve	Founder Preferred Shares Dividend Reserve Nomad has issued Founder Preferred Shares to its Founder Entities. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Annual Dividend Amount”). The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. The Preferred Shares Annual Dividend Amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last 10 consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of the Company’s ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts ($21.7289) multiplied by 140,220,619 shares (the “Preferred Share Dividend Equivalent”). The conditions of the Founder Preferred Shares Annual Dividend Amount for 2020 were met and issued on January 4, 2021. The Company issued a share dividend of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The Founder Preferred Shares automatically convert on the last day of the seventh full financial year following completion of the acquisition of the Iglo Group or upon a change of control, unless in the case of a change of control, the independent Directors determine otherwise.

Cash and cash equivalents (Tabl

Cash and cash equivalents (Tables)	9 Months Ended
	Sep. 30, 2021
Subclassifications of assets, liabilities and equities [abstract]
Summary of Cash and Cash Equivalents	September 30, 2021 December 31, 2020 €m €m Cash and cash equivalents 211.2 393.1 Restricted cash 0.4 0.1 Cash and cash equivalents 211.6 393.2 Bank overdraft — (10.7) Cash and cash equivalents per Statement of Cash Flows 211.6 382.5

Cash and cash equivalents (Deta

Cash and cash equivalents (Details) - EUR (€) € in Millions	Sep. 30, 2021	Dec. 31, 2020
Subclassifications of assets, liabilities and equities [abstract]
Cash and cash equivalents	€ 211.2	€ 393.1
Restricted cash	0.4	0.1
Cash and cash equivalents	211.6	393.2
Bank overdraft	0	(10.7)
Cash and cash equivalents per Statement of Cash Flows	€ 211.6	€ 382.5

Founder Preferred Shares Divi_2

Founder Preferred Shares Dividend Reserve (Details) € in Millions	Dec. 31, 2020EUR (€)shares
Disclosure of classes of share capital [line items]
Preferred share dividend equivalent (in shares) | shares	140,220,619
Founder Preferred shares | Founder preferred shares dividend reserve
Disclosure of classes of share capital [line items]
Equity | €	€ 245.5

General information

General information	9 Months Ended
	Sep. 30, 2021
General Information About Financial Statements [Abstract]
General information	General information These unaudited condensed consolidated interim financial statements (“interim financial statements”) as at and for the three and nine months ended September 30, 2021 comprise Nomad Foods Limited and its subsidiaries (together referred to as the “Company” or “Nomad”). Nomad Foods Limited (NYSE: NOMD) is Europe's leading frozen foods company. Nomad Foods Limited's (the “Company” or “Nomad”) portfolio of iconic brands, which includes Birds Eye , Findus , iglo , Ledo and Frikom , have been a part of consumers’ meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad Foods is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com. The Company’s sales and working capital levels have historically been affected to a limited extent by seasonality. In general, sales volumes for frozen food are slightly higher in colder or winter months and variable production costs and working capital will vary depending on the harvesting and buying periods of seasonal raw materials, in particular vegetable crops. For example, inventory levels typically peak in August to September just after the pea harvest and as a result, more working capital is required during those months. Looking ahead, the Fortenova Acquisition disclosed in Note 4 follows a different seasonality to the legacy business, with stronger performance through the summer months behind the ice-cream business. Nomad is a company registered in the British Virgin Islands and domiciled for tax in the United Kingdom.

Basis of preparation

Basis of preparation	9 Months Ended
	Sep. 30, 2021
Basis Of Presentation [Abstract]
Basis of preparation	Basis of preparation These unaudited condensed consolidated interim financial statements for the three and nine months ended September 30, 2021 have been prepared in accordance with International Accounting Standard 34, Interim Financial Reporting, as issued by the IASB and as adopted by the European Union. They do not include all the information required for a complete set of IFRS financial statements. The financial information consolidates the Company and the subsidiaries it controls and includes selected notes to explain events and transactions that are significant to an understanding of the changes in Nomad’s financial position and performance since the last annual consolidated financial statements. Therefore the unaudited condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended December 31, 2020, which have been prepared in accordance with International Financial Reporting Standards as issued by the IASB and as adopted by the European Union (“IFRS”). These unaudited condensed consolidated interim financial statements were authorized for issue by the Company’s Board of Directors on November 2, 2021. The accounting policies used by management in preparing these condensed consolidated financial statements were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2020, except for hedge accounting as disclosed in this note, accounting for certain cross currency interest rate swaps as explained in Note 12 and taxes on income. Taxes on income are accrued based on management's estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the period. It also reflects the tax impact of exceptional items accounted for in the period. The Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing the consolidated interim financial statements. On March 11, 2020, the World Health Organization officially declared COVID-19, the disease caused by novel coronavirus, a pandemic. The Directors are working with Management to monitor the evolution of the pandemic, including how it may affect the markets and the general population and also the potential financial impact. The final impact of the pandemic on the Company is hard to predict, however, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these financial statements. On January 1, 2021, the Company adopted hedge accounting under IFRS 9, as the hedge accounting requirements have been simplified and are more closely aligned to the Company's risk management strategy. Under IFRS 9 all existing hedging relationships qualified as continuing hedging relationships. Impact of adoption of IFRS 9 for hedge accounting The Company applied IFRS 9 hedge accounting prospectively, "except for application of the cost of hedging approach". The Company has elected the cost of hedging approach for the fair value movement of all hedging instruments, whereby the movements will be recognized within equity, to the extent that they relate to the hedged item. As permitted by the standard, adjustments required as a result of adopting the cost of hedging approach, have been made to the opening Consolidated Statement of Changes in Equity. As such, prior year comparatives have not been restated. A summary of adjustments arising from application of IFRS 9 for hedge accounting as of January 1, 2021 are as follows: Opening Balance Impact of change in policy Opening Balance January 1, 2021 Cash flow hedge reserve (24.5) 2.8 (21.7) Cost of hedging reserve — (4.4) (4.4) Other reserves (24.5) (1.6) (26.1) Translation reserve 84.7 1.6 86.3 The Company's policy is to reduce its risk of foreign exchange movements on forecasted transactions (such as purchases of raw materials) in currencies other than the operating entity's functional currency using forward foreign exchange contracts designated as cash flow hedges. Under IFRS 9, in cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The Company has elected to apply this accounting policy prospectively and therefore as at January 1, 2021 any existing hedges of non-financial items (such as inventory) that were already recognized in the Consolidated Statement of Financial Position, did not result in an opening balance transfer out of equity to the non-financial item as a result of the transition to IFRS 9. For the period ended September 30, 2021 €2.9 million was recognized as a basis adjustment transferred to the carrying value of inventory on the Consolidated Statement of Financial Position. This is not a reclassification adjustment and will not be recognized in the Consolidated Statement of Other Comprehensive Income for the period. Updated accounting policy for hedge accounting applied from January 1, 2021, following the adoption of IFRS 9 for hedge accounting Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge accounting relationship, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged. The Company has elected the cost of hedging approach for the fair value movement on currency basis spreads of all hedging relationships, whereby the movements will be recognized within equity, if material, to the extent that they relate to the hedged item. In cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The fair value of all financial derivative instruments (including but not limited to forward foreign exchange contracts, and cross currency interest rates swaps), is determined per market standard using forward foreign exchange and interest rates at the balance sheet date, with the resulting value discounted back to present value. Cross currency interest rate swaps can be entered into in order to mitigate perceived risks to foreign exchange translation risk and interest rate risk. Foreign exchange forward contracts can be entered into in order to mitigate perceived risks to foreign exchange transaction risk. The Company applies the hedge accounting requirements of IFRS 9 to all hedging relationships. a) Cash flow hedges Where a derivative financial instrument is designated as a hedge of the cash flow of a recognized asset or liability, (including a highly probable forecast transaction) the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve, within other reserves. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss. If the result of a forecasted transaction is recognition of a non-financial asset (for example inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve (presented together as 'Other reserves') are included in the initial cost of the non-financial item upon its recognition. For all other hedged forecasted transactions, the amounts accumulated in the hedging reserve and cost of hedging reserve are reclassified to the Consolidated Statement of Profit or Loss in the same period, or periods, in which the hedged forecasted future cash flows affect the Consolidated Statement of Profit or Loss. When a hedging instrument expires or is sold, exercised or otherwise terminated, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately. b) Net investment hedges The Company designates only the change in fair value of the spot element of the cross currency interest swap (‘spot element’) as the hedging instrument in the net investment hedge. The change in fair value of the future price element of the hedging instrument (‘forward element’) is not included as part of the hedging relationships and is recognized in the Consolidated Statement of Profit or Loss immediately. To the extent that the hedge is effective, any foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal. Interest Rate Benchmark Reform – Phase 2: Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 In August 2020, the IASB issued Interest Rate Benchmark Reform (Phase 2), which amends other IFRS standards. The amendments provide temporary reliefs which address the financial reporting effects when an interbank offered rate (IBOR) is replaced with an alternative nearly risk-free interest rate (RFR). The amendments in this final phase relate to practical expedient for particular changes in contractual cash flows, relief from specific hedge accounting requirements and certain disclosure requirement. On June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing revolving credit facility of €80 million and replace it with a new €175 million facility, paying interest rate applicable to the respective drawn down currency. Per the restated Senior Facilities Agreement, the Sterling Overnight Index Average (“SONIA”) has replaced GBP LIBOR and is effective immediately if there is a drawdown on the facility. The Secured Overnight Financing Rate (“SOFR”) will replace USD LIBOR and Swiss Average Rate Overnight (“SARON”) will replace CHF LIBOR, when existing benchmark rates are replaced. Equally, on June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to the EURIBOR (subject to a zero floor) plus 2.50%. There is currently no indication of the timing of the phase-out of EURIBOR. The Company continues to assess implications on the wider business. The existing senior USD loan of $916.4 million paying interest at a rate per annum equal to 1-month LIBOR (subject to a zero floor) plus 2.25% per annum has not been refinanced and the Company uses cross currency interest rate swaps to convert $916.4 million of Senior USD Loans at LIBOR plus 2.25% per annum, into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. The USD LIBOR phase out is expected to be completed by June 2023, therefore these amendments have no current impact on the unaudited interim condensed consolidated financial statements of the Company. As such the Company will need to renegotiate the terms of our Senior Facilities Agreement with our lenders and amend the terms of linked interest rate hedging arrangements. The Amendments are effective for annual periods beginning on or after January 1, 2021. Phase 2 amendments will require the Company to account for a change in the basis for determining the cash flows of a financial asset or a financial liability measured at amortized cost, by updating the effective interest rates as required by IBOR reform. Management continues to assess implications as a result of these amendments on the wider business. These amendments had no impact on the unaudited interim condensed consolidated financial statements of the Company for the three and nine months ended September 30, 2021. The Company intends to use the practical expedients in future periods if they become applicable.

Accounting estimates and judgme

Accounting estimates and judgments	9 Months Ended
	Sep. 30, 2021
Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]
Accounting estimates and judgments	Accounting estimates and judgmentsThe preparation of financial statements in accordance with IFRS requires the use of judgment in applying the accounting policies and estimation that affect the reported amounts of assets and liabilities and results. Actual results could differ from those estimates and the financial statements will be impacted by key judgments taken. In preparing the condensed consolidated interim financial statements, the key sources of estimation uncertainty for the interim period ended September 30, 2021, which continues to be the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2020. Key Judgments Judgments are made in the process of applying accounting policies. Those judgments which are considered key are listed below. a) Business Combinations For business combinations that have a significant effect on the amounts reported in the consolidated financial statements, the Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves judgment over whether intangible assets can be separately identified. b) Discounts and trade promotions Management use judgment when considering when accruals for discounts and trade promotions can be released. Management makes the judgment based on the principle that accruals are reversed only to the extent that it is highly probable that a significant reversal will not occur. c) Uncertain tax positions Management use judgment when determining whether it is appropriate to accrue for uncertain tax positions and for how long accruals for uncertain tax positions are retained. Management considers tax laws which are in place in making that assessment determining whether it is appropriate to release. d) Cash generating units When performing goodwill impairment testing, management apply judgment to the allocation of goodwill to cash generating units. Management has determined goodwill is monitored at the operating segment level of “Frozen”. e) Operating segments Management apply judgment in determining the Chief Operating Decision Maker (“CODM”), and the nature and extent of the financial information which is reviewed by the CODM. Management have considered how resources are allocated in determining the single reporting and operating segment of “Frozen”. Please refer to Note 5 for further information. Significant estimates Information about estimates and assumptions that have significant effects on the amounts reported in the consolidated financial statements are listed below. Management have taken into account the impact and potential future impact of COVID-19 on these estimates. Management will continue to assess the impact of future developments in relation to COVID-19 as it relates to estimates, especially around the carrying value of goodwill, brands and other intangibles, as well as on property, plant and equipment. In particular, management will focus on the long-term impact on the food service customer relationship intangible assets. a) Discounts and trade promotions Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has bespoke agreements that are governed by a combination of observable and unobservable performance conditions. Trade promotions comprise of amounts paid to retailers for programs designed to promote Company products and include pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The estimated ultimate cost of the program is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends. At each financial year end date, any discount or trade promotion incurred but not yet invoiced is estimated and accrued for. In certain cases, the estimate for discounts and trade promotions requires the use of forecast information for future trading periods and therefore a degree of estimation uncertainty exists. These estimates are sensitive to variances between actual results and forecasts. The estimate is based on accumulated experience. The accruals are presented as ‘trade terms’ and offset against trade receivables due to the same customer, or as trade term payables where there is no receivable to be offset. The balance of the reduction in trade receivables for trade terms as of September 30, 2021 is disclosed in Note 12. b) Business combinations The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable estimation in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management. The following estimates and assumptions can materially affect our financial position and profit: • The fair value and expected useful economic life of acquired intangible and tangible assets that are subject to depreciation or amortization in future periods. • Future changes to the assumptions over forecast future profitability used in estimating the value of intangible assets and goodwill may result in additional expenses or income. • Future changes to the assumptions used in estimating the value of uncertain tax positions may result in additional expenses or income. c) Carrying value of goodwill and brands Determining whether goodwill and brands are impaired requires an estimation of the value in use of the cash generating unit to which goodwill and brands have been allocated. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. Future cash flows for the purposes of the value in use calculation are taken from approved budgets. d) Employee benefit obligation The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each scheme has an actuarial valuation performed by a specialist third party and is dependent on a series of assumptions which are estimated by management. See Note 14 for details of material changes, if any, to assumptions since December 31, 2020. e) Uncertain tax positions Where tax exposures can be quantified, an accrual for uncertain tax positions is based on the Group's judgment of the most likely amount of the liability expected to be paid to the relevant tax authority; or, when there is a wide range of possible outcomes, a probability weighted average approach. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these accruals. The factors considered in estimating the accrual include the progress of discussions with the tax authorities, the complexity of respective tax legislation, valuations of assets for tax purposes and the level of documentary support for historical positions taken by previous owners. The accruals are made on the basis of a weighted average of potential outcomes. f) Fair value of derivative financial instruments. Note 12 includes details of the fair value of the derivative instruments that the Company holds at each balance sheet period. Management has estimated the fair value of these instruments by using valuations based on discounted cash flow calculations. These inputs may be readily observable, market corroborated, or generally unobservable inputs and are further discussed in Note 12.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2021
Business Combinations1 [Abstract]
Acquisitions	Acquisitions (a) Findus Switzerland On December 31, 2020, the Company completed its acquisition of all of the share capital of Findus Switzerland which produces and sells frozen food in Switzerland for €112.8 million. The deal extends the geographical reach of this brand, complementing the existing business model. Due to the timing of the acquisition, the valuation of the business had not been completed within the financial statements reported as at December 31, 2020, with the difference between the consideration paid and the book value of assets valued being provisionally allocated to goodwill. The Company has since completed a preliminary fair valuation exercise over the identifiable assets acquired as well as liabilities and contingent liabilities assumed, with any corresponding adjustment necessary being made to the value of goodwill recognized. Furthermore, following customary working capital adjustments, a final payment of €0.8 million has been made to the seller in the second quarter of 2021. The revised preliminary assessment of the assets are liabilities acquired are as follows: As reported December 31, 2020 Adjustments As restated December 31, 2020 €m €m €m Assets: Intangible assets 24.5 41.6 66.1 Property, plant and equipment, including Right-of-use assets 8.9 — 8.9 Current assets 0.2 — 0.2 Inventories 11.5 1.1 12.6 Total assets 45.1 42.7 87.8 Liabilities: Current liabilities 0.3 — 0.3 Non-current liabilities 6.8 — 6.8 Deferred tax liabilities 1.6 6.4 8.0 Total liabilities 8.7 6.4 15.1 Total identifiable net assets acquired 36.4 36.3 72.7 Total purchase consideration 112.0 0.8 112.8 Total identifiable net assets acquired (36.4) (36.3) (72.7) Goodwill 75.6 (35.5) 40.1 The preliminary goodwill recognized on acquisition is €40.1 million. The goodwill recognized is attributable mainly to the growth prospects for the business expected organically and operational synergies. If new information obtained within one year of the date of acquisition about facts and circumstances that existed at the date of acquisition is identified, then the accounting for the acquisition will be revised. The figures presented include working capital revisions post acquisition. Restatement of prior year comparatives IFRS 3 requires fair value adjustments to be recorded with effect from the date of acquisition and consequently results in the restatement of previously reported financial results. The impact on the Statement of Financial Position as at December 31, 2020 is shown below. As reported December 31, 2020 Adjustments As restated December 31, 2020 €m €m €m Goodwill 1,938.0 (35.5) 1,902.5 Intangible assets 2,114.1 41.6 2,155.7 Inventories 343.2 1.1 344.3 Deferred tax liabilities (420.7) (6.4) (427.1) Trade and other payables - current (646.4) (0.8) (647.2) Other assets and liabilities, not affected by restatement (1,202.1) — (1,202.1) Net assets 2,126.1 — 2,126.1 (b) Fortenova Group's Frozen Food Business Group On September 30, 2021, the Company announced the completion of the acquisition of the Fortenova Group’s Frozen Food Business Group (FFBG) for consideration of €640.1 million, subject to customary completion payment conditions. FFBG is a leading European frozen food portfolio operating in attractive markets new to Nomad, including Croatia, Serbia, Bosnia & Herzegovina, Hungary, Slovenia, Kosovo, North Macedonia and Montenegro. Its two anchor brands, Ledo and Frikom, have unparalleled consumer awareness and number one market share in many of these markets and offer a broad range of frozen food products including fish, fruits, vegetables, ready meals, pastry and ice cream. Due to the timing of the acquisition, the valuation of the business has not been completed, with the difference between the consideration paid and the book value of assets valued being provisionally allocated to goodwill. During the next 12 months, the Company will determine the fair value of the identifiable assets acquired as well as liabilities and contingent liabilities assumed, with any corresponding adjustment necessary being made to the value of goodwill recognized. The changes resulting from any acquisition accounting adjustments and conclusion of the completion accounts could result in material changes to the balances below. Therefore, the purchase price allocation exercise over the assets and liabilities at the date acquisition and the consideration paid, remains provisional. These were as follows: As reported September 30, 2021 €m Assets: Intangible assets 123.8 Tangible assets 77.5 Trade and other receivables 70.7 Cash 43.6 Inventories 41.0 Deferred taxes 2.9 Total assets 359.5 Liabilities: Current liabilities 52.1 Non-current liabilities 19.5 Total liabilities 71.6 Total identifiable net assets acquired 287.9 Total purchase consideration 640.1 Total identifiable net assets acquired (287.9) Goodwill 352.2 The preliminary goodwill recognized on acquisition is €352.2 million . The goodwill recognized is attributable mainly to the growth prospects for the business expected organically and operational synergies. If new information obtained within one year of the date of acquisition about facts and circumstances that existed at the date of acquisition is identified, then the accounting for the acquisition will be revised. (c) Impact of acquisitions on financial statements Acquisition related costs of €12.1 million are recognized as an expense in other operating expenses. If the acquisition had occurred on January 1, 2021, management estimates that the combined Company would have revenue of €2,142.9 million and profit before tax of €236.8 million for the nine month period ended September 30, 2021. (d) Purchase consideration - cash outflow For the nine months ended September 30, 2021 2020 Outflow of cash to acquire subsidiary, net of cash acquired €m €m Cash consideration 640.9 1.0 Less cash acquired (43.6) — Net outflow of cash - investing activities 597.3 1.0 €m Balance at January 1, 2021 15.4 Release of indemnification asset (5.5) Balance at September 30, 2021 9.9

Segment reporting

Segment reporting	9 Months Ended
	Sep. 30, 2021
Operating Segments [Abstract]
Segment reporting	Segment reporting The Chief Operating Decision Maker (“CODM”) of the Company considers there to be one reporting and operating segment, being “Frozen Foods” and is reflected in the segment presentation below for the periods presented. For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 Note €m €m €m €m Profit for the period 51.7 56.4 152.2 166.4 Taxation 13.9 14.9 42.2 48.7 Net financing costs 7 15.0 15.7 90.4 44.2 Depreciation & amortization 17.1 16.9 50.7 51.6 EBITDA 97.7 103.9 335.5 310.9 Acquisition purchase price adjustments — — 2.3 — Exceptional items 6 6.5 2.5 21.6 27.3 Other add-backs 9.0 2.3 14.4 9.2 Adjusted EBITDA 113.2 108.7 373.8 347.4 Acquisition purchase price adjustments relate to the reversal of the non-cash increase applied to inventory acquired in business combinations to value it at fair value as opposed to cost. Other add-backs include the elimination of share-based payment expense and related employer payroll tax expense of €0.8 million for the three months ended September 30, 2021 (2020: €1.7 million) and €2.3 million for the nine months ended September 30, 2021 (2020: €7.6 million), as well as the elimination of M&A costs of €8.2 million for the three months ended September 30, 2021 (2020: €0.6 million) and €12.1 million for the nine months ended September 30, 2021 (2020: €1.6 million). We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. No information on segment assets or liabilities is presented to the CODM. External revenue by geography For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 €m €m €m €m United Kingdom 182.6 173.8 564.3 555.2 Italy 90.2 88.7 310.0 311.4 Germany 86.1 86.1 288.5 285.2 France 45.0 47.4 139.8 150.1 Sweden 36.9 39.6 110.9 119.4 Austria 24.2 26.7 93.4 91.9 Norway 32.1 31.2 90.6 84.6 Spain 20.5 19.4 57.8 63.3 Rest of Europe 81.8 63.4 247.3 197.1 Total external revenue by geography 599.4 576.3 1,902.6 1,858.2

Exceptional items

Exceptional items	9 Months Ended
	Sep. 30, 2021
Analysis of income and expense [abstract]
Exceptional items	Exceptional items For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 €m €m €m €m Business transformation program 3.7 — 7.1 — Findus Switzerland integration costs 1.3 — 3.7 — Fortenova Group integration costs 0.6 — 0.6 — Release of indemnification assets — — 5.0 17.8 Brexit 0.4 0.5 4.7 0.9 Goodfella's Pizza & Aunt Bessie's integration costs — 0.7 — 3.7 Settlement of legacy matters — (1.6) (1.8) (2.7) Factory optimization 0.5 2.9 2.3 7.6 Total exceptional items 6.5 2.5 21.6 27.3 We do not consider these items to be indicative of our ongoing operating performance. In 2020, the Company launched the first phase of a multi-year, enterprise-wide transformation and optimization program. Over the next few years, additional transformation phases will be implemented. The program aims to standardize, simplify and automate end-to-end business processes. This will enable key decision making and analytical capability, building a platform and organization to support future growth and provide better value for shareholders. Execution of the business transformation program will include the evaluation and implementation of new systems needed to support the project. Expenses incurred to date consist of restructuring and transformational project costs, including business technology transformation initiative costs and related professional fees. As disclosed in Note 4, the Company completed the acquisition of Findus Switzerland on December 31, 2020 and the acquisition of Fortenova Group’s Frozen Food Business Group on September 30, 2021. Following both acquisitions, the Company is currently undertaking integration projects. The charges for the release of indemnification assets relates to the partial release of shares held in escrow associated with the acquisition of the Findus Group as discussed in Note 11. As part of the process of the United Kingdom exiting the European Union, commonly referred to as Brexit, the Company has incurred expenses to prepare for, and respond to, changes impacting our supply chain. Whilst an agreement with the EU was reached on December 24, 2020, border control processes remain in a period of transition. Expenses relating to project costs and the write-off of system development costs of €0.4 million have been recognized in the three months ended September 30, 2021 (2020: €0.5 million) and €4.7 million for the nine months ended September 30, 2021 (2020: €0.9 million). Following the acquisitions of the Goodfella’s pizza business in April 2018 and the Aunt Bessie's business in July 2018, the Company performed an integration project which was completed in 2020. In 2018, the Company initiated a three-year factory optimization program. The focus of the program is to develop a new suite of standard manufacturing and supply chain processes, that will provide a single network of optimized factories. The program is expected to provide a number of benefits, including an optimized supply chain infrastructure, benefits derived from the implementation of a standardized global manufacturing and planning processes, and an increased level of sustainable performance improvement. Expenses of €0.5 million have been incurred in the three months ended September 30, 2021 (2020: €2.9 million) and €2.3 million for the nine months ended September 30, 2021 (2020: €7.6 million). Net income in relation to the settlement of legacy matters of nil was recognized in the three months ended September 30, 2021 (2020: €1.6 million) and €1.8 million for the nine months ended September 30, 2021 (2020: €2.7 million). T he tax impact of the exceptional items for the three months ended September 30, 2021 amounted to a credit of €1.3 million (2020: €0.6 million) and a credit of €3.2 million for the nine months ended September 30, 2021 (2020: €2.2 million). Included in the Condensed Consolidated Interim Statements of Cash Flows for the nine months ended September 30, 2021 is €23.2 million (2020: €3.3 million) of cash outflows relating to exceptional items. This includes cash flows related to the above items in addition to the cash impact of the settlement of provisions brought forward from previous accounting periods.

Finance income and costs

Finance income and costs	9 Months Ended
	Sep. 30, 2021
Analysis of income and expense [abstract]
Finance income and costs	Finance income and costs For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 €m €m €m €m Finance income Interest income — 0.1 — 0.6 Reversal of impairment loss on short term investments (a) 2.8 — — — Net foreign exchange gains on translation of financial assets and liabilities 7.6 1.0 — 5.7 Total finance income 10.4 1.1 — 6.3 Interest expense (b) (15.4) (14.6) (43.0) (43.6) Net impairment loss on short term investments (a) — — (9.6) — Net foreign exchange losses arising on translation of financial assets and liabilities — — (4.5) — Net pension interest costs (0.4) (0.6) (1.2) (2.0) Amortization of borrowing costs (0.5) (0.5) (1.5) (1.5) Net fair value losses on derivatives held at fair value through profit or loss (c) (9.1) (1.1) (12.7) (3.4) Financing costs incurred on new or amended debt (d) — — (17.9) — Total finance costs (25.4) (16.8) (90.4) (50.5) Net finance costs (15.0) (15.7) (90.4) (44.2)

Taxation

Taxation	9 Months Ended
	Sep. 30, 2021
Income Taxes [Abstract]
Taxation	Taxation Income tax expense of €13.9 million for the three months ended September 30, 2021 (2020: €14.9 million) and €42.2 million for the nine months ended September 30, 2021 (2020: €48.7 million) is accrued based on management’s estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the periods. This estimate takes into account the reduction in provisions due to resolution of certain pre-acquisition risks previously covered by escrow. It also reflects the tax impact of exceptional items accounted for in the periods. The UK government announced an increase in the statutory rate of corporation tax from 19% to 25% with effect from April 1, 2023. The increase was enacted in an earlier quarter, giving rise to a substantial one-off impact on deferred tax balances in that previous quarter. The impact was offset by the implementation of certain arrangements benefiting from one-off government incentives and other tax incentives from future tax planning activities, increasing the value of deferred tax assets. The Company’s subsidiaries, which are subject to tax, operate in many different jurisdictions and, in some of these, certain tax matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve. Accruals for tax contingencies require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgment. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could in future periods experience adjustments to this provision. Management believes that the Company’s tax position on all open matters, including those in current discussion with local tax authorities, is robust and that the Company is appropriately provided.

Earnings per share

Earnings per share	9 Months Ended
	Sep. 30, 2021
Earnings per share [abstract]
Earnings per share	Earnings per share For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 Basic earnings per share Profit for the period attributable to equity owners of the parent (€m) 51.7 56.4 152.2 166.5 Weighted average Ordinary Shares and Founder Preferred Shares (basic) in millions 178.2 195.5 178.1 199.0 Basic earnings per share € 0.29 € 0.29 € 0.85 € 0.84 For the three months and nine months period ended September 30, 2021, the number of shares in both the diluted and basic earnings per share calculation has been adjusted to include shares that the Company is obligated to issue in future periods, including 24,759 shares to be issued under the 2020 Non-Executive Restricted Stock Awards in June 2022, as well as 25,655 shares to be issued under the Company's Amended and Restated Long Term 2018 Incentive Plan ("LTIP") in 2023 as performance conditions have been met. Refer to Note 15 for further details. There is no adjustment to the profit for the period attributable to equity owners of the parent. For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 Diluted earnings per share Profit for the period attributable to equity owners of the parent (€m) 51.7 56.4 152.2 166.5 Weighted average Ordinary Shares and Founder Preferred Shares (diluted) in millions 178.2 195.5 178.1 199.0 Diluted earnings per share € 0.29 € 0.29 € 0.85 € 0.84 The Ordinary Shares that could be issued to settle the Founder Preferred Shares Annual Dividend Amount are potentially dilutive, but as set out in Note 17, the Founder Preferred Shares Annual Dividend Amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last ten

Indemnification assets

Indemnification assets	9 Months Ended
	Sep. 30, 2021
Business Combinations1 [Abstract]
Indemnification assets	Acquisitions (a) Findus Switzerland On December 31, 2020, the Company completed its acquisition of all of the share capital of Findus Switzerland which produces and sells frozen food in Switzerland for €112.8 million. The deal extends the geographical reach of this brand, complementing the existing business model. Due to the timing of the acquisition, the valuation of the business had not been completed within the financial statements reported as at December 31, 2020, with the difference between the consideration paid and the book value of assets valued being provisionally allocated to goodwill. The Company has since completed a preliminary fair valuation exercise over the identifiable assets acquired as well as liabilities and contingent liabilities assumed, with any corresponding adjustment necessary being made to the value of goodwill recognized. Furthermore, following customary working capital adjustments, a final payment of €0.8 million has been made to the seller in the second quarter of 2021. The revised preliminary assessment of the assets are liabilities acquired are as follows: As reported December 31, 2020 Adjustments As restated December 31, 2020 €m €m €m Assets: Intangible assets 24.5 41.6 66.1 Property, plant and equipment, including Right-of-use assets 8.9 — 8.9 Current assets 0.2 — 0.2 Inventories 11.5 1.1 12.6 Total assets 45.1 42.7 87.8 Liabilities: Current liabilities 0.3 — 0.3 Non-current liabilities 6.8 — 6.8 Deferred tax liabilities 1.6 6.4 8.0 Total liabilities 8.7 6.4 15.1 Total identifiable net assets acquired 36.4 36.3 72.7 Total purchase consideration 112.0 0.8 112.8 Total identifiable net assets acquired (36.4) (36.3) (72.7) Goodwill 75.6 (35.5) 40.1 The preliminary goodwill recognized on acquisition is €40.1 million. The goodwill recognized is attributable mainly to the growth prospects for the business expected organically and operational synergies. If new information obtained within one year of the date of acquisition about facts and circumstances that existed at the date of acquisition is identified, then the accounting for the acquisition will be revised. The figures presented include working capital revisions post acquisition. Restatement of prior year comparatives IFRS 3 requires fair value adjustments to be recorded with effect from the date of acquisition and consequently results in the restatement of previously reported financial results. The impact on the Statement of Financial Position as at December 31, 2020 is shown below. As reported December 31, 2020 Adjustments As restated December 31, 2020 €m €m €m Goodwill 1,938.0 (35.5) 1,902.5 Intangible assets 2,114.1 41.6 2,155.7 Inventories 343.2 1.1 344.3 Deferred tax liabilities (420.7) (6.4) (427.1) Trade and other payables - current (646.4) (0.8) (647.2) Other assets and liabilities, not affected by restatement (1,202.1) — (1,202.1) Net assets 2,126.1 — 2,126.1 (b) Fortenova Group's Frozen Food Business Group On September 30, 2021, the Company announced the completion of the acquisition of the Fortenova Group’s Frozen Food Business Group (FFBG) for consideration of €640.1 million, subject to customary completion payment conditions. FFBG is a leading European frozen food portfolio operating in attractive markets new to Nomad, including Croatia, Serbia, Bosnia & Herzegovina, Hungary, Slovenia, Kosovo, North Macedonia and Montenegro. Its two anchor brands, Ledo and Frikom, have unparalleled consumer awareness and number one market share in many of these markets and offer a broad range of frozen food products including fish, fruits, vegetables, ready meals, pastry and ice cream. Due to the timing of the acquisition, the valuation of the business has not been completed, with the difference between the consideration paid and the book value of assets valued being provisionally allocated to goodwill. During the next 12 months, the Company will determine the fair value of the identifiable assets acquired as well as liabilities and contingent liabilities assumed, with any corresponding adjustment necessary being made to the value of goodwill recognized. The changes resulting from any acquisition accounting adjustments and conclusion of the completion accounts could result in material changes to the balances below. Therefore, the purchase price allocation exercise over the assets and liabilities at the date acquisition and the consideration paid, remains provisional. These were as follows: As reported September 30, 2021 €m Assets: Intangible assets 123.8 Tangible assets 77.5 Trade and other receivables 70.7 Cash 43.6 Inventories 41.0 Deferred taxes 2.9 Total assets 359.5 Liabilities: Current liabilities 52.1 Non-current liabilities 19.5 Total liabilities 71.6 Total identifiable net assets acquired 287.9 Total purchase consideration 640.1 Total identifiable net assets acquired (287.9) Goodwill 352.2 The preliminary goodwill recognized on acquisition is €352.2 million . The goodwill recognized is attributable mainly to the growth prospects for the business expected organically and operational synergies. If new information obtained within one year of the date of acquisition about facts and circumstances that existed at the date of acquisition is identified, then the accounting for the acquisition will be revised. (c) Impact of acquisitions on financial statements Acquisition related costs of €12.1 million are recognized as an expense in other operating expenses. If the acquisition had occurred on January 1, 2021, management estimates that the combined Company would have revenue of €2,142.9 million and profit before tax of €236.8 million for the nine month period ended September 30, 2021. (d) Purchase consideration - cash outflow For the nine months ended September 30, 2021 2020 Outflow of cash to acquire subsidiary, net of cash acquired €m €m Cash consideration 640.9 1.0 Less cash acquired (43.6) — Net outflow of cash - investing activities 597.3 1.0 €m Balance at January 1, 2021 15.4 Release of indemnification asset (5.5) Balance at September 30, 2021 9.9

Financial instruments

Financial instruments	9 Months Ended
	Sep. 30, 2021
Financial Instruments [Abstract]
Financial instruments	Financial instruments The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 “Financial Instruments”. Financial assets at amortized cost Derivatives at Derivatives designated in hedge relationships Financial Total September 30, 2021 €m €m €m €m €m Assets Derivative financial instruments — — 13.2 — 13.2 Trade receivables 196.7 — — — 196.7 Cash and cash equivalents 211.6 — — — 211.6 Liabilities Derivative financial instruments — (0.1) (51.0) — (51.1) Trade and other payables excluding non-financial liabilities — — — (540.5) (540.5) Loans and borrowings — — — (2,217.5) (2,217.5) Total 408.3 (0.1) (37.8) (2,758.0) (2,387.6) Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €206.3 million. Loans and borrowings includes €80.5 million relating to lease liabilities and are stated gross of capitalized deferred borrowing costs. The Company has entered into facilities with third-party banks in which the Company may sell qualifying trade debtors on a non-recourse basis. Under the terms of the agreements, the Company has transferred substantially all the credit risks and control of the receivables, which are subject to this agreement. There were no derecognized trade receivables at the period end (December 31, 2020: nil). Financial assets at amortized cost Financial assets at fair value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total December 31, 2020 €m €m €m €m €m €m Assets Derivative financial instruments — — 2.9 19.8 — 22.7 Trade receivables 141.2 — — — — 141.2 Cash and cash equivalents 393.2 — — — — 393.2 Short-term investments — 25.0 — — — 25.0 Liabilities Derivative financial instruments — — (0.2) (124.8) — (125.0) Trade and other payables excluding non-financial liabilities — — — — (601.1) (601.1) Loans and borrowings — — — — (1,765.7) (1,765.7) Total 534.4 25.0 2.7 (105.0) (2,366.8) (1,909.7) Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €200.5 million. Loans and borrowings includes €70.4 million relating to lease liabilities and are stated gross of capitalized deferred borrowing costs. The Company has determined that the carrying amount of trade receivables, trade payables and cash and cash equivalents are a reasonable approximation of fair value. Derivative financial instruments The financial instruments are not traded in an active market and so the fair value of these instruments is determined from the implied forward rate. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 “Fair value measurement”. Short-term investments Short-term investments are valued using inputs that are derived principally from or corroborated by observable market data. The Company has classified these as level 2 instruments as defined in IFRS 13 “Fair value measurement” in all periods presented. For the nine months ended September 30, 2021, the Company recognized an impairment charge of €9.6 million related to its short-term investments. The impairment charge was recognized due to a reassessment and evaluation of the observable inputs used in the valuation of the investment indicating that the full amount is likely not to be recovered. Interest bearing loans and borrowings The fair value of the senior secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the period end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities. On June 24, 2021, the Company through its indirect, wholly-owned subsidiary, Nomad Foods Bondco Plc, repaid the €400.0 million 3.25% senior secured notes due 2024 and completed a private offering of €750.0 million aggregate principal amount of 2.5% senior secured notes due June 24, 2028 (the “Notes”). Interest on the Notes accrued from the date of issue and are payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2022. The Notes are guaranteed on a senior basis by the Company and certain subsidiaries thereof. This transaction was accounted for as an extinguishment of the existing Notes and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 7. On the new Notes, eligible transaction costs of approximately €4.0 million were capitalized and will be amortized over the life of the debt. On July 9, 2021 the Company announced that Nomad Foods Bondco Plc, an indirect, wholly-owned subsidiary of the Company, completed its private offering of €50.0 million aggregate principal amount of additional 2.5% senior secured notes due 2028, representing a tack-on to the €750.0 million aggregate principal amount of senior secured notes due 2028 issued on June 24, 2021, and issued at a price of €100.75. On June 24, 2021, the Company amended and restated the Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility originally due in May 2024, through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to the applicable rate plus 2.5%. This transaction was accounted for as an extinguishment of the existing debt and previously capitalized eligible transaction costs were written-off to the Statement of Comprehensive Income, as disclosed in Note 7. On the new Senior EUR Loan, eligible transaction costs of approximately €3.8 million were capitalized and will be amortized over the life of the debt. Under the refinancing, the existing revolving credit facility of €80.0 million due 2023, was also replaced with a new €175.0 million facility (the "Revolving Credit Facility") available until June 2026 with an applicable margin of 2.25% per annum and that includes a leverage ratchet. The Revolving Credit Facility may be utilized to support working capital requirements, including letters of credit and bank guarantees. The structure of the Revolving Credit Facility now also includes a pricing structure linked to environmental impact metrics during the life of the facility, and by doing so demonstrates further commitment to the Company’s sustainability strategy by incorporating ESG target KPIs covering areas of sourcing, packaging and carbon emissions. The Company continues to have outstanding senior USD loans of $916.4 million (€789.5 million) (the “Senior USD Loan”). The Senior USD Loan is repayable in May 2024. The Senior USD Loan requires a repayment of $9.6 million (€8.3 million) in May each year until maturity equivalent to 1.0% of the original issued notional. Furthermore as part of the Senior Loan structure, the Company is additionally required to undertake an annual excess cash flow calculation whereby additional principal could be paid. The Company uses cross currency interest rate swaps (“CCIRS”) to convert its $916.4 million of floating rate Senior USD Loans into €827.8 million of EUR denominated debt with a fixed rate of interest, and designated as a cash flow hedge. On July 29, 2021 the Company extended its CCIRS used to hedge the foreign currency and interest rate risk on the current Senior Secured USD Term Loan from May 2022 to May 2024 to align with the maturity date of the USD Term Loan. As part of the transaction, the EUR fixed rate paid by the Company has been amended and reflected in the underlying interest cost. The transaction is considered to be a substantial modification of the hedging instruments, so that the this is considered to be a new hedging relationship which will give rise to some ineffectiveness in future periods. CCIRS contracts that have previously been used as a net investment hedge of the Company’s investments in Pound Sterling have also been extinguished. A change in fair value of the CCIRS arose as a consequence of the transaction, which the Company has elected to write-off immediately as a cost of extinguishment. This non-cash loss, as well as the write-off of the cost of hedging reserves associated with the discontinued net investment hedge, are presented as a one-off charge for the transaction as disclosed in Note 7. The Senior Loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries. Fair value Carrying value September 30, 2021 December 31, 2020 September 30, 2021 December 31, 2020 €m €m €m €m Senior EUR/USD loans 1,341.4 1,300.4 1,336.4 1,295.1 Other external debt 0.1 0.2 0.1 0.2 2024 fixed rate senior secured notes — 405.8 — 400.0 2028 fixed rate senior secured notes 814.3 — 800.0 — Less deferred borrowing costs — — (10.0) (6.9) 2,155.8 1,706.4 2,126.5 1,688.4

Provisions

Provisions	9 Months Ended
	Sep. 30, 2021
Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]
Provisions	Provisions Restructuring Provisions Other Total €m €m €m €m Balance as of January 1, 2021 12.9 6.6 32.3 51.8 Additional provision in the period 1.0 — 1.4 2.4 Acquired through business combinations — — 3.0 3.0 Release of provision (0.4) — (2.9) (3.3) Utilization of provision (8.0) — (6.4) (14.4) Foreign exchange — — 0.8 0.8 Balance as of September 30, 2021 5.5 6.6 28.2 40.3 Analysis of total provisions: September 30, 2021 December 31, 2020 Current 37.4 45.7 Non-current 2.9 6.1 Total 40.3 51.8 Updates since December 31, 2020 Restructuring The €5.5 million (December 31, 2020: €12.9 million) provision relates to committed plans for certain restructuring activities of an exceptional nature which are due to be completed within the next 12 months. €8.0 million has been utilized in the nine months ended September 30, 2021, which relates to reorganizational activities across the Company. Other Other provisions cover a range of liabilities, including €1.9 million (December 31, 2020: €6.6 million) related to employer taxes on the LTIP which become payable on the issuance of shares (see Note 15), of which €5.8 million has been utilized in the nine months ended September 30, 2021.

Employee benefits

Employee benefits	9 Months Ended
	Sep. 30, 2021
Employee Benefits [Abstract]
Employee benefits	Employee benefits The Company operates partially funded defined benefit pension plans in Germany and Austria, an unfunded defined benefit pension plan in Sweden and defined benefit indemnity arrangements in Italy and Austria, as well as various contribution plans in other countries. Pension benefits in Switzerland are met via a contract with a collective foundation that offers a fully insured solution to provide a contribution-based cash balance retirement plan, which is classified as a defined benefit plan. In addition, an unfunded post-retirement medical plan is operated in Austria. In Germany and Italy, long term service awards are in operation and various other countries provide other employee benefits. There were no changes in the nature of any schemes in the nine months ended September 30, 2021. The total net employee benefit obligations as at September 30, 2021 is as follows: €m Balance as of January 1, 2021 276.2 Acquired through business combinations 4.2 Service cost 6.0 Net interest expense 1.2 Actuarial gains on pension scheme valuations (32.3) Benefits paid (5.3) Foreign exchange differences on translation (0.8) Balance as of September 30, 2021 249.2

Share based compensation reserv

Share based compensation reserve	9 Months Ended
	Sep. 30, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Disclosure of Share Based Compensation Reserve	Share based compensation reserve During 2015, the Company established a discretionary share award scheme, the LTIP, which enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. The Compensation Committee currently awards grants to Senior Management, including those that are Directors and Non-Executive Directors. All Awards are to be settled by physical delivery of shares. Director and Senior Management Share Awards As part of its long term incentive initiatives, the Company has awarded restricted shares to the management team (the “Management Share Awards”) as of the following five award dates. January 1, 2016 Award January 1, 2017 Award January 1, 2018 Award January 1, 2019 Award January 1, 2020 Award Total Number of awards outstanding at January 1, 2021 1,041,953 819,873 446,575 159,561 710,438 3,178,400 Forfeitures in the period — — (14,785) (6,866) (33,196) (54,847) Awards vested and issued in period (1,041,953) (819,873) — — — (1,861,826) Number of awards outstanding at September 30, 2021 — — 431,790 152,695 677,242 1,261,727 Relevant to the January 1, 2016, 2017 and 2018 awards schemes grant, the vesting of such awards is subject to the following performance conditions: up to one-half of such award will vest if the Company achieves one of a range of benchmark market share price performance targets over a revised four or five year period (the "Share Price Performance Condition") and up to one-half of such award will vest upon the Company achieving one of a range of cumulative EBITDA performance targets over a four-year period (the "EBITDA Performance Condition"). If the Share Price Performance Condition is satisfied, up to 50% of the shares subject to the Share Price Performance Condition will vest in the initial two-year period following the grant and up to 50% of the shares subject to the Share Price Performance Condition will vest over the subsequent two or three-year period following the grant, depending on the award. • For the 2016 award, the initial two-year period is through to January 1, 2018 and the subsequent three-year period is through to January 1, 2021. All awards for this grant have now vested. • For the 2017 award, the initial two-year period is through to January 1, 2019 and the subsequent two-year period is through to January 1, 2021. All awards for this grant have now vested. • For the 2018 award, the initial two-year period is through to January 1, 2020 and the subsequent three-year period is through to January 1, 2023. With respect to each such award, if the respective EBITDA Performance Condition is satisfied, up to 50% of such award subject to the EBITDA Performance Condition will vest on January 1, 2021 and 2022, respectively, as the case may be. In September 2019, 173,293 restricted share awards were granted as part of the 2019 Management Share Award. The performance period associated with the award began on January 1, 2019. The Share awards will vest on the Company achieving a range of performance conditions including cumulative EBITDA, cumulative net sales, and share price performance measures over a three-year period. One third of the total share award is assigned to each type of performance measure. All shares are subject to a holding period of an additional year and require that the participants to the scheme are still actively employed during the entire four year period, through January 1, 2023. In January 2020, 761,979 restricted share awards were granted as part of the 2020 Management Share Award. The performance period associated with the award began on January 1, 2020. The Share awards will vest on the Company achieving a range of performance conditions including cumulative EBITDA, cumulative net sales, and share price performance measures over a three-year period. The cumulative EBITDA and Cumulative Net Sales tranches of shares are equally weighted, being worth 37.5% of the total award each. The Share Price Tranche is worth 25% of the total award. All shares are subject to a holding period of an additional year and require that the participants to the scheme are still actively employed during the entire four year period, through January 1, 2024. In January 2021, 1,041,953 restricted shares granted as part of the 2016 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.42), resulting in the issuance of 587,633 ordinary shares to participants in the LTIP (net of 454,320 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares). In January 2021, 368,154 restricted shares granted as part of the 2017 Management Share Awards vested as a result of the satisfaction of the applicable Share Price Performance Condition (based on a share price of $25.42), resulting in the issuance of 217,228 ordinary shares to participants in the LTIP (net of 150,926 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares). In February 2021, 451,719 restricted shares granted as part of the 2017 Management Share Awards vested as a result of the satisfaction of the applicable EBITDA Performance Condition (based on a share price of $25.89 at time of vesting), resulting in the issuance of 271,451 ordinary shares to participants in the LTIP (net of 180,268 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares). The stock compensation charge reported within the Consolidated Statement of Profit or Loss for the three and nine months ended September 30, 2021 related to the Director and Senior Management Share Awards is €0.4 million and €1.2 million (three and nine months ended September 30, 2020: €0.7 million and €4.8 million). The Company calculates the cost of the Management Share Awards based upon their fair value using the Monte Carlo Model, which is considered to be the most appropriate methodology considering the restricted shares only vest once the market performance conditions have been satisfied, as well as expected exercise period and the payment of dividends by the Company. Based on the latest revision to the January 1, 2018, 2019 and 2020 schemes, the inputs and assumptions underlying the Monte Carlo models for all awards outstanding as of valuation date are as follows: January 1, 2018 Award January 1, 2019 Award January 1, 2020 Award Grant date price $ 16.72 $ 20.15 $ 22.37 Exercise price $ — $ — $ — Expected life of restricted share 1.50 – 4.00 years 4.00 years 4.00 years Expected volatility of the share price 22.7 % 24.0 % 24.4 % Dividend yield expected — % — % — % Risk free rate 2.55 % 1.33 % 1.70 % Employee exit rate 14.0 % 14.0 % 27.3 % EBITDA Performance Target Conditions 35.0 % 35.0 % 35.0 % The expected volatility of the share price inputs above were estimated by referencing selected quoted companies which are considered to exhibit some degree of comparability with the Company, as the Company has been listed less than five years at the point of issue. Based on the assessment of fair value and the number of shares expected to vest, the total fair value in respect of the Restricted Shares outstanding are: • 2018 award - $1.6 million (€1.3 million) • 2019 award - $1.4 million (€1.2 million) • 2020 award - $4.8 million (€4.3 million) Non-Executive Director Restricted Share Awards In accordance with the Board approved independent Non-Executive Director compensation guidelines, each independent Non-Executive Director is granted $100,000 of restricted shares annually on the date of the annual general meeting, valued at the closing market price for such shares on this date. The restricted shares vest on the earlier to occur of the date of the Company’s annual meeting of shareholders or thirteen months from the date of grant. On June 17, 2020 after the Company's annual meeting of shareholders, the current Non-Executive Directors were granted 32,140 restricted stock awards at a share price of $21.78. The Non-Executive Directors restricted share awards identified above vested on June 30, 2021 and 24,406 were issued. Of the total 32,140 number of shares vesting, 7,734 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares. On June 30, 2021, after the Company's annual general meeting, the current Non-Executive Directors were granted 24,759 restricted stock awards at a share price of $28.27. The total charge within the Statement of Consolidated Profit or Loss for the three and nine months ended September 30, 2021 related to Non-Executive Directors stock compensation awards was €0.2 million and €0.6 million (three and nine months ended September 30, 2020: €0.2 million and €0.5 million). Share based compensation reserve Total Share based €m Balance as of January 1, 2021 8.3 Non-Executive Director restricted share awards charge 0.6 Directors and Senior Management share awards charge - January 1, 2018 0.2 Directors and Senior Management share awards charge - January 1, 2019 0.2 Directors and Senior Management share awards charge - January 1, 2020 0.8 Shares issued upon vesting of Awards (0.7) Reclassification of employer tax for Director and Senior Management share awards (5.6) Balance as of September 30, 2021 3.8 In many jurisdictions, tax authorities levy taxes on share-based payment transactions with employees that give rise to a personal tax liability for the employee. In some cases, the Company is required to withhold the tax due and to settle it with the tax authority on behalf of the employees. To fulfill this obligation, the terms of the Management Share Awards permit the Company to withhold the number of shares that are equal to the monetary value of the employee’s tax obligation from the total number of shares that otherwise would have been issued to the employee upon vesting. The monetary value of the employee’s tax obligation is recorded as a deduction from Share based compensation reserve for the shares withheld.
Share based compensation reserve	Founder Preferred Shares Dividend Reserve Nomad has issued Founder Preferred Shares to its Founder Entities. Holders of the Founder Preferred Shares are entitled to receive annual dividend amounts subject to certain performance conditions (the “Founder Preferred Shares Annual Dividend Amount”). The Founder Preferred Shares Annual Dividend Amount is structured to provide a dividend based on the future appreciation of the market value of the ordinary shares, thus aligning the interests of the Founders with those of the investors on a long term basis. The Preferred Shares Annual Dividend Amount is determined with reference to the Dividend Determination Period of a financial year, i.e. the last 10 consecutive trading days and calculated as 20% of the increase in the volume weighted average share price of the Company’s ordinary shares across the determination period compared to the highest price previously used in calculating the Founder Preferred Share Annual Dividend Amounts ($21.7289) multiplied by 140,220,619 shares (the “Preferred Share Dividend Equivalent”). The conditions of the Founder Preferred Shares Annual Dividend Amount for 2020 were met and issued on January 4, 2021. The Company issued a share dividend of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten The Founder Preferred Shares Annual Dividend Amount is paid for so long as the Founder Preferred Shares remain outstanding. The Founder Preferred Shares automatically convert on the last day of the seventh full financial year following completion of the acquisition of the Iglo Group or upon a change of control, unless in the case of a change of control, the independent Directors determine otherwise.

Share Capital and Capital reser

Share Capital and Capital reserve	9 Months Ended
	Sep. 30, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Share Capital and Capital reserve	Share Capital, Capital reserve and Other reserves Ordinary Shares On January 4, 2021, the Company issued a share dividend of 3,875,036 ordinary shares calculated as 20% of the increase in the market price of our ordinary shares compared to 2019 dividend price of $21.7289 multiplied by Preferred Share Dividend Equivalent. The Dividend Price used to calculate the Annual Dividend Amount was $25.2127 (calculated based upon the volume weighted average price for the last ten On March 13, 2020, the Company announced a share repurchase program to purchase up to an aggregate of $300 million of the Company’s ordinary shares. Acquisitions pursuant to the stock repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. From January 1, 2021 to January 8, 2021, the Company entered into agreements to repurchase and cancel 507,396 ordinary shares in open market transactions for $12.8 million (€10.5 million) under the program. On August 5, 2021, the Company announced that its Board of Directors authorized a share repurchase program to purchase up to an aggregate of $500 million of the Company’s ordinary shares. Acquisitions pursuant to the share repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions, at the Company's discretion, as permitted by securities laws and other legal requirements. See Note 15 for further information on restricted shares vested as part of the 2016 and 2017 Management Share Awards. The following is the authorized share capital available to the Company: • Unlimited number of Ordinary Shares with $nil nominal value issued at $10.00 per share • Unlimited number of Founder Preferred Shares with $nil nominal value issued at $10.00 per share Shares September 30, 2021 December 31, 2020 September 30, 2021 December 31, 2020 €m €m Authorized Share Capital issued and fully paid: Ordinary Shares with nil nominal value 176,649,255 172,180,897 1,679.6 1,636.9 Founder Preferred Shares with nil nominal value 1,500,000 1,500,000 10.6 10.6 Total share capital and capital reserve 1,690.2 1,647.5 Listing and share transaction costs — (27.0) Total net share capital and capital reserve 1,690.2 1,620.5 Other Reserves Other reserves as at September 30, 2021, include a cash flow hedging reserve of €7.0 million (December 31, 2020: deficit of €21.7 million as restated in Note 2) and a cost of hedging reserve with a deficit of €1.1 million (December 31, 2020: deficit of €4.4 million as restated in Note 2).

Related parties

Related parties	9 Months Ended
	Sep. 30, 2021
Related Party [Abstract]
Related parties	Related parties Mariposa Capital, LLC, an affiliate of Sir Martin Franklin, and TOMS Capital LLC, an affiliate of Mr. Gottesman, perform advisory services on behalf of the Company. The total fees and expenses incurred by them in the course of their duties for the three and nine months ended September 30, 2021 were €0.4 million and €1.2 million respectively (three and nine months ended September 30, 2020: €0.4 million and €1.4 million respectively). In addition to the fees above, as discussed in Note 17, the conditions of the Founder Preferred Shares Annual Dividend Amount for 2020 were met and a share dividend of 3,875,036 ordinary shares was issued on January 4, 2021. Key management personnel comprise the Directors and Executive Officers. The Executive Officers continue to be remunerated for their services to the Company through their employment contracts. Non-executive Directors continue to receive fees for their services as board members and to certain committees and are settled through payroll. Director fees are payable quarterly in arrears. Total non-executive Director fees and expenses for the three and nine months ended September 30, 2021 was €0.1 million and €0.3 million respectively (three and nine months ended September 30, 2020: €0.1 million and €0.3 million respectively). In addition, certain non-executive Directors received grants under the LTIP as discussed in Note 15.

Subsequent events after the Sta

Subsequent events after the Statement of Financial Position date	9 Months Ended
	Sep. 30, 2021
Events After Reporting Period [Abstract]
Subsequent events after the Statement of Financial Position date	Subsequent events after the Statement of Financial Position date

Basis of preparation (Policies)

Basis of preparation (Policies)	9 Months Ended
	Sep. 30, 2021
Common Domain Members [Abstract]
Basis of Presentation	The accounting policies used by management in preparing these condensed consolidated financial statements were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2020, except for hedge accounting as disclosed in this note, accounting for certain cross currency interest rate swaps as explained in Note 12 and taxes on income. Taxes on income are accrued based on management's estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the period. It also reflects the tax impact of exceptional items accounted for in the period. The Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing the consolidated interim financial statements. On March 11, 2020, the World Health Organization officially declared COVID-19, the disease caused by novel coronavirus, a pandemic. The Directors are working with Management to monitor the evolution of the pandemic, including how it may affect the markets and the general population and also the potential financial impact. The final impact of the pandemic on the Company is hard to predict, however, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these financial statements. On January 1, 2021, the Company adopted hedge accounting under IFRS 9, as the hedge accounting requirements have been simplified and are more closely aligned to the Company's risk management strategy. Under IFRS 9 all existing hedging relationships qualified as continuing hedging relationships. Impact of adoption of IFRS 9 for hedge accounting The Company applied IFRS 9 hedge accounting prospectively, "except for application of the cost of hedging approach". The Company has elected the cost of hedging approach for the fair value movement of all hedging instruments, whereby the movements will be recognized within equity, to the extent that they relate to the hedged item. As permitted by the standard, adjustments required as a result of adopting the cost of hedging approach, have been made to the opening Consolidated Statement of Changes in Equity. As such, prior year comparatives have not been restated. A summary of adjustments arising from application of IFRS 9 for hedge accounting as of January 1, 2021 are as follows: Opening Balance Impact of change in policy Opening Balance January 1, 2021 Cash flow hedge reserve (24.5) 2.8 (21.7) Cost of hedging reserve — (4.4) (4.4) Other reserves (24.5) (1.6) (26.1) Translation reserve 84.7 1.6 86.3 The Company's policy is to reduce its risk of foreign exchange movements on forecasted transactions (such as purchases of raw materials) in currencies other than the operating entity's functional currency using forward foreign exchange contracts designated as cash flow hedges. Under IFRS 9, in cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The Company has elected to apply this accounting policy prospectively and therefore as at January 1, 2021 any existing hedges of non-financial items (such as inventory) that were already recognized in the Consolidated Statement of Financial Position, did not result in an opening balance transfer out of equity to the non-financial item as a result of the transition to IFRS 9. For the period ended September 30, 2021 €2.9 million was recognized as a basis adjustment transferred to the carrying value of inventory on the Consolidated Statement of Financial Position. This is not a reclassification adjustment and will not be recognized in the Consolidated Statement of Other Comprehensive Income for the period. Updated accounting policy for hedge accounting applied from January 1, 2021, following the adoption of IFRS 9 for hedge accounting Derivative financial instruments are recognized at fair value. When a derivative financial instrument is not designated in a hedge accounting relationship, all changes in its fair value are recognized immediately in the Consolidated Statement of Profit or Loss. However, where derivatives qualify for hedge accounting, recognition of any resultant gain or loss depends on the nature of the item being hedged. The Company has elected the cost of hedging approach for the fair value movement on currency basis spreads of all hedging relationships, whereby the movements will be recognized within equity, if material, to the extent that they relate to the hedged item. In cash flow hedges of a forecast transaction that result in the recognition of a non-financial item (such as inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve are included in the initial cost of the non-financial item upon its recognition. The fair value of all financial derivative instruments (including but not limited to forward foreign exchange contracts, and cross currency interest rates swaps), is determined per market standard using forward foreign exchange and interest rates at the balance sheet date, with the resulting value discounted back to present value. Cross currency interest rate swaps can be entered into in order to mitigate perceived risks to foreign exchange translation risk and interest rate risk. Foreign exchange forward contracts can be entered into in order to mitigate perceived risks to foreign exchange transaction risk. The Company applies the hedge accounting requirements of IFRS 9 to all hedging relationships. a) Cash flow hedges Where a derivative financial instrument is designated as a hedge of the cash flow of a recognized asset or liability, (including a highly probable forecast transaction) the effective part of any gain or loss on the derivative financial instrument is recognized directly in the cash flow hedging reserve, within other reserves. Any ineffective portion of the hedge is recognized immediately in the Consolidated Statement of Profit or Loss. If the result of a forecasted transaction is recognition of a non-financial asset (for example inventory), the amounts that were accumulated in the cash flow hedging reserve and the cost of hedging reserve (presented together as 'Other reserves') are included in the initial cost of the non-financial item upon its recognition. For all other hedged forecasted transactions, the amounts accumulated in the hedging reserve and cost of hedging reserve are reclassified to the Consolidated Statement of Profit or Loss in the same period, or periods, in which the hedged forecasted future cash flows affect the Consolidated Statement of Profit or Loss. When a hedging instrument expires or is sold, exercised or otherwise terminated, or the entity revokes designation of the hedge relationship but the hedged forecast transaction is still expected to occur, the cumulative gain or loss at that point remains in equity and is recognized when the transaction occurs. If the hedged transaction is no longer expected to take place, the cumulative unrealized gain or loss recognized in equity is recognized in the Consolidated Statement of Profit or Loss immediately. b) Net investment hedges The Company designates only the change in fair value of the spot element of the cross currency interest swap (‘spot element’) as the hedging instrument in the net investment hedge. The change in fair value of the future price element of the hedging instrument (‘forward element’) is not included as part of the hedging relationships and is recognized in the Consolidated Statement of Profit or Loss immediately. To the extent that the hedge is effective, any foreign currency differences arising on the retranslation of the spot rate component of a financial liability designated as a hedge of a net investment in a foreign operation are recognized in Other Comprehensive Income, and are presented in the translation reserve within equity. To the extent that the hedge is ineffective, such differences are recognized in the Consolidated Statement of Profit or Loss. When the hedged net investment is disposed of, the relevant amount in the translation reserve is transferred to the Consolidated Statement of Profit or Loss as part of the gain or loss on disposal. Interest Rate Benchmark Reform – Phase 2: Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 In August 2020, the IASB issued Interest Rate Benchmark Reform (Phase 2), which amends other IFRS standards. The amendments provide temporary reliefs which address the financial reporting effects when an interbank offered rate (IBOR) is replaced with an alternative nearly risk-free interest rate (RFR). The amendments in this final phase relate to practical expedient for particular changes in contractual cash flows, relief from specific hedge accounting requirements and certain disclosure requirement. On June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing revolving credit facility of €80 million and replace it with a new €175 million facility, paying interest rate applicable to the respective drawn down currency. Per the restated Senior Facilities Agreement, the Sterling Overnight Index Average (“SONIA”) has replaced GBP LIBOR and is effective immediately if there is a drawdown on the facility. The Secured Overnight Financing Rate (“SOFR”) will replace USD LIBOR and Swiss Average Rate Overnight (“SARON”) will replace CHF LIBOR, when existing benchmark rates are replaced. Equally, on June 24, 2021, the Company amended and restated its Senior Facilities Agreement to refinance its existing €553.2 million senior secured term loan facility through a new 7-year term facility due 2028 (the "Senior EUR Loan"), paying interest at a rate equal to the EURIBOR (subject to a zero floor) plus 2.50%. There is currently no indication of the timing of the phase-out of EURIBOR. The Company continues to assess implications on the wider business. The existing senior USD loan of $916.4 million paying interest at a rate per annum equal to 1-month LIBOR (subject to a zero floor) plus 2.25% per annum has not been refinanced and the Company uses cross currency interest rate swaps to convert $916.4 million of Senior USD Loans at LIBOR plus 2.25% per annum, into €827.8 million of EUR denominated debt with a fixed rate of interest, designated as a cash flow hedge. The USD LIBOR phase out is expected to be completed by June 2023, therefore these amendments have no current impact on the unaudited interim condensed consolidated financial statements of the Company. As such the Company will need to renegotiate the terms of our Senior Facilities Agreement with our lenders and amend the terms of linked interest rate hedging arrangements. The Amendments are effective for annual periods beginning on or after January 1, 2021. Phase 2 amendments will require the Company to account for a change in the basis for determining the cash flows of a financial asset or a financial liability measured at amortized cost, by updating the effective interest rates as required by IBOR reform. Management continues to assess implications as a result of these amendments on the wider business. These amendments had no impact on the unaudited interim condensed consolidated financial statements of the Company for the three and nine months ended September 30, 2021. The Company intends to use the practical expedients in future periods if they become applicable.

Segment reporting (Tables)

Segment reporting (Tables)	9 Months Ended
	Sep. 30, 2021
Operating Segments [Abstract]
Segment As Adjusted EBITDA	The Chief Operating Decision Maker (“CODM”) of the Company considers there to be one reporting and operating segment, being “Frozen Foods” and is reflected in the segment presentation below for the periods presented. For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 Note €m €m €m €m Profit for the period 51.7 56.4 152.2 166.4 Taxation 13.9 14.9 42.2 48.7 Net financing costs 7 15.0 15.7 90.4 44.2 Depreciation & amortization 17.1 16.9 50.7 51.6 EBITDA 97.7 103.9 335.5 310.9 Acquisition purchase price adjustments — — 2.3 — Exceptional items 6 6.5 2.5 21.6 27.3 Other add-backs 9.0 2.3 14.4 9.2 Adjusted EBITDA 113.2 108.7 373.8 347.4
External Revenue by Geography	External revenue by geography For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 €m €m €m €m United Kingdom 182.6 173.8 564.3 555.2 Italy 90.2 88.7 310.0 311.4 Germany 86.1 86.1 288.5 285.2 France 45.0 47.4 139.8 150.1 Sweden 36.9 39.6 110.9 119.4 Austria 24.2 26.7 93.4 91.9 Norway 32.1 31.2 90.6 84.6 Spain 20.5 19.4 57.8 63.3 Rest of Europe 81.8 63.4 247.3 197.1 Total external revenue by geography 599.4 576.3 1,902.6 1,858.2

Exceptional items (Tables)

Exceptional items (Tables)	9 Months Ended
	Sep. 30, 2021
Analysis of income and expense [abstract]
Schedule of Exceptional Items	For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 €m €m €m €m Business transformation program 3.7 — 7.1 — Findus Switzerland integration costs 1.3 — 3.7 — Fortenova Group integration costs 0.6 — 0.6 — Release of indemnification assets — — 5.0 17.8 Brexit 0.4 0.5 4.7 0.9 Goodfella's Pizza & Aunt Bessie's integration costs — 0.7 — 3.7 Settlement of legacy matters — (1.6) (1.8) (2.7) Factory optimization 0.5 2.9 2.3 7.6 Total exceptional items 6.5 2.5 21.6 27.3

Finance income and costs (Table

Finance income and costs (Tables)	9 Months Ended
	Sep. 30, 2021
Analysis of income and expense [abstract]
Schedule of Finance income and costs	For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 €m €m €m €m Finance income Interest income — 0.1 — 0.6 Reversal of impairment loss on short term investments (a) 2.8 — — — Net foreign exchange gains on translation of financial assets and liabilities 7.6 1.0 — 5.7 Total finance income 10.4 1.1 — 6.3 Interest expense (b) (15.4) (14.6) (43.0) (43.6) Net impairment loss on short term investments (a) — — (9.6) — Net foreign exchange losses arising on translation of financial assets and liabilities — — (4.5) — Net pension interest costs (0.4) (0.6) (1.2) (2.0) Amortization of borrowing costs (0.5) (0.5) (1.5) (1.5) Net fair value losses on derivatives held at fair value through profit or loss (c) (9.1) (1.1) (12.7) (3.4) Financing costs incurred on new or amended debt (d) — — (17.9) — Total finance costs (25.4) (16.8) (90.4) (50.5) Net finance costs (15.0) (15.7) (90.4) (44.2) (a) For the nine months ended September 30, 2021, the Company has a net impairment charge of €9.6 million related to its short-term investments. An impairment was recognized in March 2021 but has since been partially reversed in the three months ended September 30, 2021. These reversals are presented as finance income in the period in the three months ended September 30, 2021. (b) Interest expense includes interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss and is shown net of gains recycled from the cash flow hedge reserve on cross currency interest rate swaps. (c) For the nine months ended September 30, 2021, net fair value losses on derivatives held at fair value through profit or loss includes a one-off non-cash charge of €7.8 million for changes to cross currency interest rate swaps as disclosed in Note 12. (d) For the nine months ended September 30, 2021, charges of €17.9 million have been recognized as a consequence of the refinancing in June 2021, as disclosed in Note 12. Of this, €10.1 million relates to the extinguishment of the previous debts, including the write-off of deferred transaction costs.

Earnings per share (Tables)

Earnings per share (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings per share [abstract]
Schedule of Earnings per Share	For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 Basic earnings per share Profit for the period attributable to equity owners of the parent (€m) 51.7 56.4 152.2 166.5 Weighted average Ordinary Shares and Founder Preferred Shares (basic) in millions 178.2 195.5 178.1 199.0 Basic earnings per share € 0.29 € 0.29 € 0.85 € 0.84
Schedule of Diluted Earnings per Share	For the three months ended September 30, For the nine months ended September 30, 2021 2020 2021 2020 Diluted earnings per share Profit for the period attributable to equity owners of the parent (€m) 51.7 56.4 152.2 166.5 Weighted average Ordinary Shares and Founder Preferred Shares (diluted) in millions 178.2 195.5 178.1 199.0 Diluted earnings per share € 0.29 € 0.29 € 0.85 € 0.84

Indemnification assets (Tables)

Indemnification assets (Tables)	9 Months Ended
	Sep. 30, 2021
Business Combinations1 [Abstract]
Summary of Indemnification Assets	Acquisitions (a) Findus Switzerland On December 31, 2020, the Company completed its acquisition of all of the share capital of Findus Switzerland which produces and sells frozen food in Switzerland for €112.8 million. The deal extends the geographical reach of this brand, complementing the existing business model. Due to the timing of the acquisition, the valuation of the business had not been completed within the financial statements reported as at December 31, 2020, with the difference between the consideration paid and the book value of assets valued being provisionally allocated to goodwill. The Company has since completed a preliminary fair valuation exercise over the identifiable assets acquired as well as liabilities and contingent liabilities assumed, with any corresponding adjustment necessary being made to the value of goodwill recognized. Furthermore, following customary working capital adjustments, a final payment of €0.8 million has been made to the seller in the second quarter of 2021. The revised preliminary assessment of the assets are liabilities acquired are as follows: As reported December 31, 2020 Adjustments As restated December 31, 2020 €m €m €m Assets: Intangible assets 24.5 41.6 66.1 Property, plant and equipment, including Right-of-use assets 8.9 — 8.9 Current assets 0.2 — 0.2 Inventories 11.5 1.1 12.6 Total assets 45.1 42.7 87.8 Liabilities: Current liabilities 0.3 — 0.3 Non-current liabilities 6.8 — 6.8 Deferred tax liabilities 1.6 6.4 8.0 Total liabilities 8.7 6.4 15.1 Total identifiable net assets acquired 36.4 36.3 72.7 Total purchase consideration 112.0 0.8 112.8 Total identifiable net assets acquired (36.4) (36.3) (72.7) Goodwill 75.6 (35.5) 40.1 The preliminary goodwill recognized on acquisition is €40.1 million. The goodwill recognized is attributable mainly to the growth prospects for the business expected organically and operational synergies. If new information obtained within one year of the date of acquisition about facts and circumstances that existed at the date of acquisition is identified, then the accounting for the acquisition will be revised. The figures presented include working capital revisions post acquisition. Restatement of prior year comparatives IFRS 3 requires fair value adjustments to be recorded with effect from the date of acquisition and consequently results in the restatement of previously reported financial results. The impact on the Statement of Financial Position as at December 31, 2020 is shown below. As reported December 31, 2020 Adjustments As restated December 31, 2020 €m €m €m Goodwill 1,938.0 (35.5) 1,902.5 Intangible assets 2,114.1 41.6 2,155.7 Inventories 343.2 1.1 344.3 Deferred tax liabilities (420.7) (6.4) (427.1) Trade and other payables - current (646.4) (0.8) (647.2) Other assets and liabilities, not affected by restatement (1,202.1) — (1,202.1) Net assets 2,126.1 — 2,126.1 (b) Fortenova Group's Frozen Food Business Group On September 30, 2021, the Company announced the completion of the acquisition of the Fortenova Group’s Frozen Food Business Group (FFBG) for consideration of €640.1 million, subject to customary completion payment conditions. FFBG is a leading European frozen food portfolio operating in attractive markets new to Nomad, including Croatia, Serbia, Bosnia & Herzegovina, Hungary, Slovenia, Kosovo, North Macedonia and Montenegro. Its two anchor brands, Ledo and Frikom, have unparalleled consumer awareness and number one market share in many of these markets and offer a broad range of frozen food products including fish, fruits, vegetables, ready meals, pastry and ice cream. Due to the timing of the acquisition, the valuation of the business has not been completed, with the difference between the consideration paid and the book value of assets valued being provisionally allocated to goodwill. During the next 12 months, the Company will determine the fair value of the identifiable assets acquired as well as liabilities and contingent liabilities assumed, with any corresponding adjustment necessary being made to the value of goodwill recognized. The changes resulting from any acquisition accounting adjustments and conclusion of the completion accounts could result in material changes to the balances below. Therefore, the purchase price allocation exercise over the assets and liabilities at the date acquisition and the consideration paid, remains provisional. These were as follows: As reported September 30, 2021 €m Assets: Intangible assets 123.8 Tangible assets 77.5 Trade and other receivables 70.7 Cash 43.6 Inventories 41.0 Deferred taxes 2.9 Total assets 359.5 Liabilities: Current liabilities 52.1 Non-current liabilities 19.5 Total liabilities 71.6 Total identifiable net assets acquired 287.9 Total purchase consideration 640.1 Total identifiable net assets acquired (287.9) Goodwill 352.2 The preliminary goodwill recognized on acquisition is €352.2 million . The goodwill recognized is attributable mainly to the growth prospects for the business expected organically and operational synergies. If new information obtained within one year of the date of acquisition about facts and circumstances that existed at the date of acquisition is identified, then the accounting for the acquisition will be revised. (c) Impact of acquisitions on financial statements Acquisition related costs of €12.1 million are recognized as an expense in other operating expenses. If the acquisition had occurred on January 1, 2021, management estimates that the combined Company would have revenue of €2,142.9 million and profit before tax of €236.8 million for the nine month period ended September 30, 2021. (d) Purchase consideration - cash outflow For the nine months ended September 30, 2021 2020 Outflow of cash to acquire subsidiary, net of cash acquired €m €m Cash consideration 640.9 1.0 Less cash acquired (43.6) — Net outflow of cash - investing activities 597.3 1.0 €m Balance at January 1, 2021 15.4 Release of indemnification asset (5.5) Balance at September 30, 2021 9.9

Financial instruments (Tables)

Financial instruments (Tables)	9 Months Ended
	Sep. 30, 2021
Financial Instruments [Abstract]
Disclosure of Financial Assets	Financial assets at amortized cost Derivatives at Derivatives designated in hedge relationships Financial Total September 30, 2021 €m €m €m €m €m Assets Derivative financial instruments — — 13.2 — 13.2 Trade receivables 196.7 — — — 196.7 Cash and cash equivalents 211.6 — — — 211.6 Liabilities Derivative financial instruments — (0.1) (51.0) — (51.1) Trade and other payables excluding non-financial liabilities — — — (540.5) (540.5) Loans and borrowings — — — (2,217.5) (2,217.5) Total 408.3 (0.1) (37.8) (2,758.0) (2,387.6) Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €206.3 million. Loans and borrowings includes €80.5 million relating to lease liabilities and are stated gross of capitalized deferred borrowing costs. The Company has entered into facilities with third-party banks in which the Company may sell qualifying trade debtors on a non-recourse basis. Under the terms of the agreements, the Company has transferred substantially all the credit risks and control of the receivables, which are subject to this agreement. There were no derecognized trade receivables at the period end (December 31, 2020: nil). Financial assets at amortized cost Financial assets at fair value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total December 31, 2020 €m €m €m €m €m €m Assets Derivative financial instruments — — 2.9 19.8 — 22.7 Trade receivables 141.2 — — — — 141.2 Cash and cash equivalents 393.2 — — — — 393.2 Short-term investments — 25.0 — — — 25.0 Liabilities Derivative financial instruments — — (0.2) (124.8) — (125.0) Trade and other payables excluding non-financial liabilities — — — — (601.1) (601.1) Loans and borrowings — — — — (1,765.7) (1,765.7) Total 534.4 25.0 2.7 (105.0) (2,366.8) (1,909.7)
Disclosure of Financial Liabilities	Financial assets at amortized cost Derivatives at Derivatives designated in hedge relationships Financial Total September 30, 2021 €m €m €m €m €m Assets Derivative financial instruments — — 13.2 — 13.2 Trade receivables 196.7 — — — 196.7 Cash and cash equivalents 211.6 — — — 211.6 Liabilities Derivative financial instruments — (0.1) (51.0) — (51.1) Trade and other payables excluding non-financial liabilities — — — (540.5) (540.5) Loans and borrowings — — — (2,217.5) (2,217.5) Total 408.3 (0.1) (37.8) (2,758.0) (2,387.6) Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €206.3 million. Loans and borrowings includes €80.5 million relating to lease liabilities and are stated gross of capitalized deferred borrowing costs. The Company has entered into facilities with third-party banks in which the Company may sell qualifying trade debtors on a non-recourse basis. Under the terms of the agreements, the Company has transferred substantially all the credit risks and control of the receivables, which are subject to this agreement. There were no derecognized trade receivables at the period end (December 31, 2020: nil). Financial assets at amortized cost Financial assets at fair value through profit or loss Derivatives at Derivatives designated in hedge relationships Financial Total December 31, 2020 €m €m €m €m €m €m Assets Derivative financial instruments — — 2.9 19.8 — 22.7 Trade receivables 141.2 — — — — 141.2 Cash and cash equivalents 393.2 — — — — 393.2 Short-term investments — 25.0 — — — 25.0 Liabilities Derivative financial instruments — — (0.2) (124.8) — (125.0) Trade and other payables excluding non-financial liabilities — — — — (601.1) (601.1) Loans and borrowings — — — — (1,765.7) (1,765.7) Total 534.4 25.0 2.7 (105.0) (2,366.8) (1,909.7) Fair value Carrying value September 30, 2021 December 31, 2020 September 30, 2021 December 31, 2020 €m €m €m €m Senior EUR/USD loans 1,341.4 1,300.4 1,336.4 1,295.1 Other external debt 0.1 0.2 0.1 0.2 2024 fixed rate senior secured notes — 405.8 — 400.0 2028 fixed rate senior secured notes 814.3 — 800.0 — Less deferred borrowing costs — — (10.0) (6.9) 2,155.8 1,706.4 2,126.5 1,688.4

Provisions (Tables)

Provisions (Tables)	9 Months Ended
	Sep. 30, 2021
Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]
Summary of Provisions	Restructuring Provisions Other Total €m €m €m €m Balance as of January 1, 2021 12.9 6.6 32.3 51.8 Additional provision in the period 1.0 — 1.4 2.4 Acquired through business combinations — — 3.0 3.0 Release of provision (0.4) — (2.9) (3.3) Utilization of provision (8.0) — (6.4) (14.4) Foreign exchange — — 0.8 0.8 Balance as of September 30, 2021 5.5 6.6 28.2 40.3 Analysis of total provisions: September 30, 2021 December 31, 2020 Current 37.4 45.7 Non-current 2.9 6.1 Total 40.3 51.8

Employee benefits (Tables)

Employee benefits (Tables)	9 Months Ended
	Sep. 30, 2021
Employee Benefits [Abstract]
Schedule of Net Employee Benefit Obligations	The total net employee benefit obligations as at September 30, 2021 is as follows: €m Balance as of January 1, 2021 276.2 Acquired through business combinations 4.2 Service cost 6.0 Net interest expense 1.2 Actuarial gains on pension scheme valuations (32.3) Benefits paid (5.3) Foreign exchange differences on translation (0.8) Balance as of September 30, 2021 249.2

Share based compensation rese_2

Share based compensation reserve (Tables)	9 Months Ended
	Sep. 30, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Summary of Management Share Awards	As part of its long term incentive initiatives, the Company has awarded restricted shares to the management team (the “Management Share Awards”) as of the following five award dates. January 1, 2016 Award January 1, 2017 Award January 1, 2018 Award January 1, 2019 Award January 1, 2020 Award Total Number of awards outstanding at January 1, 2021 1,041,953 819,873 446,575 159,561 710,438 3,178,400 Forfeitures in the period — — (14,785) (6,866) (33,196) (54,847) Awards vested and issued in period (1,041,953) (819,873) — — — (1,861,826) Number of awards outstanding at September 30, 2021 — — 431,790 152,695 677,242 1,261,727
Summary of Management Share Award Inputs and Assumptions	Based on the latest revision to the January 1, 2018, 2019 and 2020 schemes, the inputs and assumptions underlying the Monte Carlo models for all awards outstanding as of valuation date are as follows: January 1, 2018 Award January 1, 2019 Award January 1, 2020 Award Grant date price $ 16.72 $ 20.15 $ 22.37 Exercise price $ — $ — $ — Expected life of restricted share 1.50 – 4.00 years 4.00 years 4.00 years Expected volatility of the share price 22.7 % 24.0 % 24.4 % Dividend yield expected — % — % — % Risk free rate 2.55 % 1.33 % 1.70 % Employee exit rate 14.0 % 14.0 % 27.3 % EBITDA Performance Target Conditions 35.0 % 35.0 % 35.0 %
Schedule of Reserves within Equity	Share based compensation reserve Total Share based €m Balance as of January 1, 2021 8.3 Non-Executive Director restricted share awards charge 0.6 Directors and Senior Management share awards charge - January 1, 2018 0.2 Directors and Senior Management share awards charge - January 1, 2019 0.2 Directors and Senior Management share awards charge - January 1, 2020 0.8 Shares issued upon vesting of Awards (0.7) Reclassification of employer tax for Director and Senior Management share awards (5.6) Balance as of September 30, 2021 3.8

Share Capital and Capital res_2

Share Capital and Capital reserve (Tables)	9 Months Ended
	Sep. 30, 2021
Share Capital, Reserves and Other Equity Interest [Abstract]
Schedule of Share Capital and Capital Reserve	Shares September 30, 2021 December 31, 2020 September 30, 2021 December 31, 2020 €m €m Authorized Share Capital issued and fully paid: Ordinary Shares with nil nominal value 176,649,255 172,180,897 1,679.6 1,636.9 Founder Preferred Shares with nil nominal value 1,500,000 1,500,000 10.6 10.6 Total share capital and capital reserve 1,690.2 1,647.5 Listing and share transaction costs — (27.0) Total net share capital and capital reserve 1,690.2 1,620.5

Basis of preparation (Details)

Basis of preparation (Details) € in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2021EUR (€)	Sep. 30, 2021USD ($)	Sep. 29, 2021EUR (€)	Jun. 24, 2021EUR (€)	Jan. 01, 2021EUR (€)	Dec. 31, 2020EUR (€)
Common Table Line Items [Line Items]
Other reserves	€ 5.9		€ 7		€ (21.7)	€ (24.5)
Reserve of change in value of forward elements of forward contracts			€ (1.1)		(4.4)	0
Other reserves					(26.1)	(24.5)
Translation reserve	92.1				86.3	€ 84.7
Derivatives | Swap contract | Cash flow hedges
Common Table Line Items [Line Items]
Notional amount	€ 827.8
Revolving Credit Facility (new)
Common Table Line Items [Line Items]
Line of credit facility, maximum borrowing capacity				€ 175
Senior EURO Debt
Common Table Line Items [Line Items]
Notional amount				€ 553.2
Interest rate	2.50%	2.50%
Senior USD Debt
Common Table Line Items [Line Items]
Notional amount	€ 789.5	$ 916.4
Interest rate	2.25%	2.25%
Other reserves*
Common Table Line Items [Line Items]
Deferred hedging losses and costs of hedging transferred to the carrying value of inventory	€ 2.9
Increase (decrease) due to changes in accounting policy [member]
Common Table Line Items [Line Items]
Other reserves					2.8
Reserve of change in value of forward elements of forward contracts					(4.4)
Other reserves					(1.6)
Translation reserve					€ 1.6

Acquisitions (Details)

Acquisitions (Details) - EUR (€) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Disclosure of detailed information about business combination [line items]
Consideration paid (received)			€ 640.9	€ 1
Assets	€ 6,074.6		6,074.6		€ 5,580.6
Liabilities	3,761.8		3,761.8		3,454.5
Cash and cash equivalents in subsidiary or businesses acquired or disposed			(43.6)	0
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities			597.3	1
Acquisition related costs	8.2	€ 0.6	12.1	€ 1.6
Revenue of combined entity as if combination occurred at beginning of period			2,142.9
Profit (loss) of combined entity as if combination occurred at beginning of period			236.8
Findus Switzerland
Disclosure of detailed information about business combination [line items]
Consideration transferred					112.8
Identifiable intangible assets recognised as of acquisition date					66.1
Inventory recognised as of acquisition date					12.6
Current assets recognised as of acquisition date					0.2
Property, plant and equipment recognised as of acquisition date					8.9
Assets					87.8
Current liabilities recognised as of acquisition date					0.3
Non-current liabilities recognised as of acquisition date					6.8
Deferred tax liabilities recognised as of acquisition date					8
Liabilities					15.1
Identifiable assets acquired (liabilities assumed)					(72.7)
Contingent consideration recognised as of acquisition date	0.8		0.8
Goodwill recognised as of acquisition date					40.1
Findus Switzerland | Previously stated [member]
Disclosure of detailed information about business combination [line items]
Consideration transferred					112
Identifiable intangible assets recognised as of acquisition date					24.5
Inventory recognised as of acquisition date					11.5
Current assets recognised as of acquisition date					0.2
Property, plant and equipment recognised as of acquisition date					8.9
Assets					45.1
Current liabilities recognised as of acquisition date					0.3
Non-current liabilities recognised as of acquisition date					6.8
Deferred tax liabilities recognised as of acquisition date					1.6
Liabilities					8.7
Identifiable assets acquired (liabilities assumed)					(36.4)
Goodwill recognised as of acquisition date					75.6
Findus Switzerland | Increase (decrease) due to corrections of prior period errors [member]
Disclosure of detailed information about business combination [line items]
Consideration transferred					0.8
Identifiable intangible assets recognised as of acquisition date					41.6
Inventory recognised as of acquisition date					1.1
Current assets recognised as of acquisition date					0
Property, plant and equipment recognised as of acquisition date					0
Assets					42.7
Current liabilities recognised as of acquisition date					0
Non-current liabilities recognised as of acquisition date					0
Deferred tax liabilities recognised as of acquisition date					6.4
Liabilities					6.4
Identifiable assets acquired (liabilities assumed)					(36.3)
Goodwill recognised as of acquisition date					€ (35.5)
Fortenova Group
Disclosure of detailed information about business combination [line items]
Identifiable intangible assets recognised as of acquisition date	123.8		123.8
Other tangible or intangible assets transferred	77.5		77.5
Trade and other receivables	70.7		70.7
Cash and cash equivalents recognised as of acquisition date	43.6		43.6
Inventory recognised as of acquisition date	41		41
Deferred tax assets recognised as of acquisition date	2.9		2.9
Assets	359.5		359.5
Current liabilities recognised as of acquisition date	52.1		52.1
Non-current liabilities recognised as of acquisition date	19.5		19.5
Liabilities	71.6		71.6
Identifiable assets acquired (liabilities assumed)	(287.9)		(287.9)
Contingent consideration recognised as of acquisition date	640.1		640.1
Goodwill recognised as of acquisition date	€ 352.2		€ 352.2

Acquisitions (Details)_2

Acquisitions (Details) - EUR (€) € in Millions	Sep. 30, 2021	Dec. 31, 2020
Disclosure of reclassifications or changes in presentation [line items]
Goodwill	€ 2,256	€ 1,902.5
Intangibles	2,274.2	2,155.7
Inventories	427.5	344.3
Deferred tax liabilities	(374.4)	(427.1)
Trade and other payables	(608.4)	(647.2)
Other assets		(1,202.1)
Assets (liabilities)	€ 2,312.8	2,126.1
Previously stated [member]
Disclosure of reclassifications or changes in presentation [line items]
Goodwill		1,938
Intangibles		2,114.1
Inventories		343.2
Deferred tax liabilities		(420.7)
Trade and other payables		(646.4)
Other assets		(1,202.1)
Assets (liabilities)		2,126.1
Increase (decrease) due to corrections of prior period errors [member]
Disclosure of reclassifications or changes in presentation [line items]
Goodwill		(35.5)
Intangibles		41.6
Inventories		1.1
Deferred tax liabilities		6.4
Trade and other payables		0.8
Other assets		0
Assets (liabilities)		€ 0

Segment reporting - Segment as

Segment reporting - Segment as Adjusted EBITDA (Details) - EUR (€) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disclosure of operating segments [line items]
Profit for the period	€ 51.7	€ 56.4	€ 152.2	€ 166.4
Taxation	13.9	14.9	42.2	48.7
Net financing costs	15	15.7	90.4	44.2
Depreciation & amortization	17.1	16.9	50.7	51.6
EBITDA	97.7	103.9	335.5	310.9
Exceptional items	6.5	2.5	21.6	27.3
Material reconciling items
Disclosure of operating segments [line items]
Acquisition purchase price adjustments	0	0	2.3	0
Exceptional items	6.5	2.5	21.6	27.3
Other add-backs	9	2.3	14.4	9.2
Adjusted EBITDA	€ 113.2	€ 108.7	€ 373.8	€ 347.4

Segment reporting - Additional

Segment reporting - Additional Information (Details) - EUR (€) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Operating Segments [Abstract]
Adjustments for share based payments including employer tax	€ 0.8	€ 1.7	€ 2.3	€ 7.6
Acquisition related costs	€ 8.2	€ 0.6	€ 12.1	€ 1.6

Segment reporting - Geographica

Segment reporting - Geographical information (Details) - EUR (€) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disclosure of geographical areas [line items]
Revenue	€ 599.4	€ 576.3	€ 1,902.6	€ 1,858.2
United Kingdom
Disclosure of geographical areas [line items]
Revenue	182.6	173.8	564.3	555.2
Italy
Disclosure of geographical areas [line items]
Revenue	90.2	88.7	310	311.4
Germany
Disclosure of geographical areas [line items]
Revenue	86.1	86.1	288.5	285.2
France
Disclosure of geographical areas [line items]
Revenue	45	47.4	139.8	150.1
Sweden
Disclosure of geographical areas [line items]
Revenue	36.9	39.6	110.9	119.4
Austria
Disclosure of geographical areas [line items]
Revenue	24.2	26.7	93.4	91.9
Norway
Disclosure of geographical areas [line items]
Revenue	32.1	31.2	90.6	84.6
Spain
Disclosure of geographical areas [line items]
Revenue	20.5	19.4	57.8	63.3
Rest of Europe
Disclosure of geographical areas [line items]
Revenue	€ 81.8	€ 63.4	€ 247.3	€ 197.1

Exceptional Items - Schedule (D

Exceptional Items - Schedule (Details) - EUR (€) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Analysis of income and expense [abstract]
Business transformation program	€ 3.7	€ 0	€ 7.1	€ 0
Findus Switzerland integration costs	1.3	0	3.7	0
Fortenova Group integration costs	0.6	0	0.6	0
Release of indemnification assets	0	0	5.5	17.8
Brexit	0.4	0.5	4.7	0.9
Goodfella's Pizza & Aunt Bessie's integration costs	0	0.7	0	3.7
Settlement of legacy matters	0	(1.6)	(1.8)	(2.7)
Factory optimization	0.5	2.9	2.3	7.6
Exceptional items	€ 6.5	€ 2.5	€ 21.6	€ 27.3

Exceptional items - Additional

Exceptional items - Additional Information (Details) - EUR (€) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Analysis of income and expense [abstract]
Business transformation program	€ 3.7	€ 0	€ 7.1	€ 0
Brexit	0.4	0.5	4.7	0.9
Goodfella's Pizza & Aunt Bessie's integration costs	0	0.7	0	3.7
Factory optimization	0.5	2.9	2.3	7.6
Exceptional Items, Tax Expense (Income), Continuing Operations	€ (1.3)	€ (0.6)	(3.2)	(2.2)
Cash flows relating to exceptional items			€ (23.2)	€ (3.3)

Finance income and costs (Detai

Finance income and costs (Details) - EUR (€)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Analysis of income and expense [abstract]
Interest income	€ 0	€ 100,000	€ 0	€ 600,000
Reversal of impairment loss on short term investments (a)	2,800,000	0	0	0
Net foreign exchange gains on translation of financial assets and liabilities	7,600,000	1,000,000	0	5,700,000
Total finance income	10,400,000	1,100,000	0	6,300,000
Interest expense (b)	(15,400,000)	(14,600,000)	(43,000,000)	(43,600,000)
Net impairment loss on short term investments (a)	0	0	(9,600,000)	0
Net foreign exchange losses arising on translation of financial assets and liabilities	0	0	(4,500,000)	0
Net pension interest costs	(400,000)	(600,000)	(1,200,000)	(2,000,000)
Amortization of borrowing costs	(500,000)	(500,000)	(1,500,000)	(1,500,000)
Net fair value losses on derivatives held at fair value through profit or loss (c)	(9,100,000)	(1,100,000)	(12,700,000)	(3,400,000)
Financing costs incurred on new or amended debt (d)	0	0	(17,900,000)	0
Total finance costs	(25,400,000)	(16,800,000)	(90,400,000)	(50,500,000)
Net finance costs	€ 15,000,000	€ 15,700,000	90,400,000	€ 44,200,000
Gains (Losses) on Restructuring of previous debt			10,100,000
Non-cash loss recognized in relation to cross currency interest rate swaps			€ 7,800,000

Taxation (Details)

Taxation (Details) - EUR (€) € in Millions	Apr. 01, 2023	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Taxes [Abstract]
Tax expense		€ 13.9	€ 14.9	€ 42.2	€ 48.7
Applicable tax rate	2500.00%			1900.00%

Earnings per share - Computatio

Earnings per share - Computation (Details) - EUR (€) € / shares in Units, € in Millions, shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Basic earnings per share
Profit for the period attributable to equity owners of the parent (€m)	€ 51.7	€ 56.4	€ 152.2	€ 166.5
Weighted average Ordinary Shares and Founder Preferred Shares (basic) in millions	178.2	195.5	178.1	199
Basic earnings per share	€ 0.29	€ 0.29	€ 0.85	€ 0.84
Diluted earnings per share
Profit for the period attributable to equity owners of the parent (€m)	€ 51.7	€ 56.4	€ 152.2	€ 166.5
Weighted average Ordinary Shares and Founder Preferred Shares (diluted) in millions	178.2	195.5	178.1	199
Diluted earnings per share	€ 0.29	€ 0.29	€ 0.85	€ 0.84

Earnings per share - Additional

Earnings per share - Additional Information (Details)	Jun. 30, 2021	Jun. 17, 2020	Sep. 30, 2021shares	Jun. 30, 2021	Sep. 30, 2021
Earnings per share [line items]
Preference shares, dividend payment terms, weighted average share price, minimum term required				10 days	10 days
January 1, 2018
Earnings per share [line items]
Dilutive effect of restricted share awards on number of ordinary shares (in shares)			25,655
Non-Executive Director
Earnings per share [line items]
Number of other equity instruments exercised or vested in share-based payment arrangement	24,759	32,140			24,406
Key management personnel of entity or parent
Earnings per share [line items]
Number of other equity instruments exercised or vested in share-based payment arrangement			24,759

Indemnification assets (Details

Indemnification assets (Details) - EUR (€) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Business Combinations1 [Abstract]
Beginning balance			€ 15.4
Release of indemnified provision	€ 0	€ 0	(5.5)	€ (17.8)
Ending balance	€ 9.9		€ 9.9

Indemnification assets - Additi

Indemnification assets - Additional Information (Details) € / shares in Units, € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021EUR (€)€ / sharesshares	Sep. 30, 2020EUR (€)	Sep. 30, 2021EUR (€)€ / sharesshares	Sep. 30, 2020EUR (€)	Sep. 30, 2021$ / shares	Dec. 31, 2020EUR (€)€ / sharesshares	Dec. 31, 2020$ / shares
Disclosure of detailed information about business combination [line items]
Release of indemnified provision	€ 0	€ 0	€ (5.5)	€ (17.8)
Findus
Disclosure of detailed information about business combination [line items]
Indemnification assets recognised as of acquisition date	€ 7		€ 7			€ 12
Shares held in escrow as a result of indemnification asset (in shares) | shares	342,190		342,190			618,099
Value of shares held in escrow as a result of indemnification asset (price per share) | (per share)	€ 23.74		€ 23.74		$ 27.56	€ 20.69	$ 25.42
Release of indemnified provision			€ (5)
Contingent Consideration Arrangements And Indemnification Assets Recognised as of Acquisition Date, shares released from escrow | shares	275,909		275,909
Goodfella's Pizza
Disclosure of detailed information about business combination [line items]
Contingent consideration arrangements and indemnification assets recognised as of acquisition date, acquisitions	€ 2.9		€ 2.9			€ 3.4

Financial instruments - Categor

Financial instruments - Categories of financial instruments (Details) - EUR (€) € in Millions	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2019
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at amortized cost	€ 211.6	€ 393.2	€ 552.3	€ 824.8
Financial assets at amortised cost	408.3	534.4
Financial assets at fair value through profit or loss		25
Financial liabilities at amortised cost	(2,758)	(2,366.8)
Financial assets (liabilities) at fair value through profit or loss	(0.1)	2.7
Financial assets (liabilities) at fair value through other comprehensive income	(37.8)	(105)
Total	(2,387.6)	(1,909.7)
Derivative financial instruments
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities at amortised cost	0	0
Financial liabilities	(51.1)	(125)
Financial liabilities at fair value through profit or loss	(0.1)	(0.2)
Financial Liabilities At Fair Value Through Other Comprehensive Income	(51)	(124.8)
Trade and other payables excluding non-financial liabilities
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities at amortised cost	(540.5)	(601.1)
Financial liabilities	(540.5)	(601.1)
Financial liabilities at fair value through profit or loss	0	0
Financial Liabilities At Fair Value Through Other Comprehensive Income	0	0
Loans and borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial liabilities at amortised cost	(2,217.5)	(1,765.7)
Financial liabilities	(2,217.5)	(1,765.7)
Financial liabilities at fair value through profit or loss	0	0
Financial Liabilities At Fair Value Through Other Comprehensive Income	0	0
Derivative financial instruments
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss	0	2.9
Financial assets	13.2	22.7
Derivative financial assets held for hedging	13.2	19.8
Trade receivables
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at amortised cost	196.7	141.2
Financial assets	196.7	141.2
Cash and cash equivalents
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at amortised cost	211.6	393.2
Financial assets	€ 211.6	393.2
Short-term investments [Member]
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Financial assets at fair value through profit or loss		25
Financial assets		€ 25

Financial Instruments - Additio

Financial Instruments - Additional Information (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021EUR (€)	Sep. 30, 2020EUR (€)	Sep. 30, 2021EUR (€)	Sep. 30, 2021USD ($)	Sep. 30, 2020EUR (€)	Sep. 30, 2021USD ($)	Jul. 09, 2021EUR (€)	Jun. 24, 2021EUR (€)	Dec. 31, 2020EUR (€)
Disclosure of detailed information about borrowings [line items]
Contract liabilities	€ 206,300,000		€ 206,300,000						€ 200,500,000
Recognised assets representing continuing involvement in derecognised financial assets	0		0						0
Financing costs incurred on new or amended debt (d)	0	€ 0	(17,900,000)		€ 0
Derivatives | Swap contract | Cash flow hedges
Disclosure of detailed information about borrowings [line items]
Notional amount	827,800,000		827,800,000
Liability relating to IFRS 16
Disclosure of detailed information about borrowings [line items]
Lease liabilities	€ 80,500,000		€ 80,500,000						€ 70,400,000
Senior EURO Debt
Disclosure of detailed information about borrowings [line items]
Notional amount								€ 553,200,000
Interest rate	2.50%		2.50%			2.50%
Financing costs incurred on new or amended debt (d)			€ 3,800,000
Senior USD Debt
Disclosure of detailed information about borrowings [line items]
Notional amount	€ 789,500,000		789,500,000			$ 916.4
Repayments of non-current borrowings			€ 8,300,000	$ 9.6
Interest rate	2.25%		2.25%			2.25%
Revolving Credit Facility
Disclosure of detailed information about borrowings [line items]
Line of credit facility, maximum borrowing capacity								80,000,000
2024 fixed rate senior secured notes
Disclosure of detailed information about borrowings [line items]
Notional amount								€ 400,000,000
Interest rate								3.25%
Twenty Twenty-Eight Fixed Rate Senior Secured Notes
Disclosure of detailed information about borrowings [line items]
Notional amount	€ 750,000,000		€ 750,000,000				€ 50,000,000	€ 750,000,000
Interest rate	2.50%		2.50%			2.50%	2.50%
Financing costs incurred on new or amended debt (d)			€ 4,000,000
Issued price of Senior Secured Notes (2028)							€ 100.75
Revolving Credit Facility (new)
Disclosure of detailed information about borrowings [line items]
Line of credit facility, maximum borrowing capacity								€ 175,000,000

Financial Instruments - Interes

Financial Instruments - Interest bearing loans and borrowings (Details) $ in Millions	9 Months Ended
	Sep. 30, 2021EUR (€)	Sep. 30, 2021USD ($)	Sep. 30, 2021USD ($)	Jul. 09, 2021EUR (€)	Jun. 24, 2021EUR (€)	Dec. 31, 2020EUR (€)
2024 fixed rate senior secured notes
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Notional amount					€ 400,000,000
Interest rate					3.25%
Twenty Twenty-Eight Fixed Rate Senior Secured Notes
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Notional amount	€ 750,000,000			€ 50,000,000	€ 750,000,000
Interest rate	2.50%		2.50%	2.50%
Issued price of Senior Secured Notes (2028)				€ 100.75
Senior USD Debt
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Notional amount	€ 789,500,000		$ 916.4
Interest rate	2.25%		2.25%
Repayments of non-current borrowings	€ 8,300,000	$ 9.6
Repayments Of Non-current Borrowings - percentage of original issued notional	1.00%		1.00%
Loans and Borrowings
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Fair value	€ 2,155,800,000					€ 1,706,400,000
Carrying value	2,126,500,000					1,688,400,000
Loans and Borrowings | Deferred borrowing costs
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Fair value	0					0
Carrying value	(10,000,000)					(6,900,000)
Loans and Borrowings | Senior EUR/USD loans
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Carrying value	1,336,400,000					1,295,100,000
Loans and Borrowings | Senior EUR/USD loans | Level 2
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Fair value	1,341,400,000					1,300,400,000
Loans and Borrowings | Other borrowings [Domain]
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Fair value	100,000					200,000
Carrying value	100,000					200,000
Loans and Borrowings | 2024 fixed rate senior secured notes
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Carrying value	0					400,000,000
Loans and Borrowings | 2024 fixed rate senior secured notes | Level 1
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Fair value	0					405,800,000
Loans and Borrowings | Twenty Twenty-Eight Fixed Rate Senior Secured Notes
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Carrying value	800,000,000					0
Loans and Borrowings | Twenty Twenty-Eight Fixed Rate Senior Secured Notes | Level 1
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]
Fair value	€ 814,300,000					€ 0

Provisions - Schedule (Details)

Provisions - Schedule (Details) - EUR (€) € in Millions	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Disclosure of other provisions [line items]
Other provisions at beginning of period	€ 51.8
Additional provision in the period	2.4
Acquired through business combinations	3
Release of provision	(3.3)
Utilization of provision	(14.4)
Foreign exchange	0.8
Other provisions at end of period	40.3
Current	37.4	€ 45.7
Non-current	2.9	6.1
Provisions	40.3	€ 51.8
Restructuring
Disclosure of other provisions [line items]
Other provisions at beginning of period	12.9
Additional provision in the period	1
Acquired through business combinations	0
Release of provision	(0.4)
Utilization of provision	(8)
Foreign exchange	0
Other provisions at end of period	5.5
Provisions related to other taxes
Disclosure of other provisions [line items]
Other provisions at beginning of period	6.6
Additional provision in the period	0
Acquired through business combinations	0
Release of provision	0
Utilization of provision	0
Foreign exchange	0
Other provisions at end of period	6.6
Other
Disclosure of other provisions [line items]
Other provisions at beginning of period	32.3
Additional provision in the period	1.4
Acquired through business combinations	3
Release of provision	(2.9)
Utilization of provision	(6.4)
Foreign exchange	0.8
Other provisions at end of period	€ 28.2

Provisions - Additional Informa

Provisions - Additional Information (Details) - EUR (€) € in Millions	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Disclosure of other provisions [line items]
Other provisions	€ 40.3	€ 51.8
Provision used, other provisions	14.4
Restructuring
Disclosure of other provisions [line items]
Other provisions	€ 5.5	12.9
Estimated completion of activities	12 months
Provision used, other provisions	€ 8
Provision for employer taxes on share based payments
Disclosure of other provisions [line items]
Other provisions	1.9	€ 6.6
Provision used, other provisions	€ 5.8

Employee Benefits (Details)

Employee Benefits (Details) - EUR (€) € in Millions	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Employee Benefits [Abstract]
Net defined benefit liability (asset) at beginning of period	€ 276.2
Acquired through business combinations	4.2
Service cost	6
Net interest expense	1.2
Actuarial gains on pension scheme valuations	(32.3)
Benefits paid	(5.3)
Foreign exchange differences on translation	(0.8)
Net defined benefit liability (asset) at end of period	€ 249.2
Germany
Disclosure of defined benefit plans [line items]
Actuarial assumption of discount rates	1.10%	0.55%

Share based compensation rese_3

Share based compensation reserve - Director and Senior Management Share Awards (Details) - Restricted shares - shares	1 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of other equity instruments outstanding (in shares) at beginning of period		3,178,400
Forfeitures in the period (in shares)		(54,847)
Awards vested and issued in period (in shares)		(1,861,826)
Number of other equity instruments outstanding (in shares) at end of period		1,261,727
Management Award 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
New awards granted in the period (in shares)	173,293
New awards granted in the period (in shares)	173,293
January 1, 2016
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of other equity instruments outstanding (in shares) at beginning of period		1,041,953
Forfeitures in the period (in shares)		0
Awards vested and issued in period (in shares)		(1,041,953)
Number of other equity instruments outstanding (in shares) at end of period		0
January 1, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of other equity instruments outstanding (in shares) at beginning of period		819,873
Forfeitures in the period (in shares)		0
Awards vested and issued in period (in shares)		(819,873)
Number of other equity instruments outstanding (in shares) at end of period		0
January 1, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of other equity instruments outstanding (in shares) at beginning of period		446,575
Forfeitures in the period (in shares)		(14,785)
Awards vested and issued in period (in shares)		0
Number of other equity instruments outstanding (in shares) at end of period		431,790
January 1, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of other equity instruments outstanding (in shares) at beginning of period		159,561
Forfeitures in the period (in shares)		(6,866)
Awards vested and issued in period (in shares)		0
Number of other equity instruments outstanding (in shares) at end of period		152,695
January 1, 2020
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of other equity instruments outstanding (in shares) at beginning of period		710,438
Forfeitures in the period (in shares)		(33,196)
Awards vested and issued in period (in shares)		0
Number of other equity instruments outstanding (in shares) at end of period		677,242

Share based compensation rese_4

Share based compensation reserve - Director and Senior Management Share Awards (Narrative) (Details) $ / shares in Units, € in Millions, $ in Millions

1 Months Ended

3 Months Ended

9 Months Ended

Feb. 28, 2021shares

Jan. 31, 2021shares

Sep. 30, 2019shares

Sep. 30, 2021EUR (€)

Sep. 30, 2020EUR (€)

Sep. 30, 2021EUR (€)shares

Sep. 30, 2020EUR (€)

Feb. 01, 2021$ / shares

Jan. 01, 2021$ / shares

Jan. 31, 2020

Jan. 01, 2020EUR (€)

Jan. 01, 2020USD ($)

Jan. 01, 2019EUR (€)

Jan. 01, 2019USD ($)

Jan. 01, 2018EUR (€)

Jan. 01, 2018USD ($)

Disclosure of terms and conditions of share-based payment arrangement [line items]

Key management personnel compensation | €

€ 0.4

€ 0.7

€ 1.2

€ 4.8

Weighted average fair value at measurement date, other equity instruments granted

€ 4.3

$ 4.8

€ 1.2

$ 1.4

€ 1.3

$ 1.6

Restricted shares

Disclosure of terms and conditions of share-based payment arrangement [line items]

Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)

1,861,826

Restricted shares | Management Award 2019

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting period

3 years

New awards granted in the period (in shares)

173,293

Restricted shares | Management Award 2020

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting period

3 years

Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)

761,979

EBITDA and cumulative net sales tranches as percent of total award

37.50%

Share price tranche as percent of total award

25.00%

Restricted shares | Management Award 2016

Disclosure of terms and conditions of share-based payment arrangement [line items]

Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)

1,041,953

Liabilities from share-based payment transactions (in shares)

454,320

Shares issued, price per share (in dollars per share) | $ / shares

$ 25.42

Restricted shares | Management Award 2016 | Ordinary shares

Disclosure of terms and conditions of share-based payment arrangement [line items]

Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)

587,633

Restricted shares | Management Award 2017 [Member]

Disclosure of terms and conditions of share-based payment arrangement [line items]

Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)

451,719

368,154

Liabilities from share-based payment transactions (in shares)

180,268

150,926

Shares issued, price per share (in dollars per share) | $ / shares

$ 25.89

$ 25.42

Restricted shares | Management Award 2017 [Member] | Ordinary shares

Disclosure of terms and conditions of share-based payment arrangement [line items]

Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)

271,451

217,228

Restricted shares | January 1, 2016

Disclosure of terms and conditions of share-based payment arrangement [line items]

Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)

1,041,953

Restricted shares | January 1, 2017

Disclosure of terms and conditions of share-based payment arrangement [line items]

Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)

819,873

Restricted shares | January 1, 2018

Disclosure of terms and conditions of share-based payment arrangement [line items]

Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)

0

Restricted shares | Key management personnel of entity or parent | Share-based Compensation Award, Tranche Two | January 1, 2016

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting period

3 years

Restricted shares | Key management personnel of entity or parent | Share-based Compensation Award, Tranche Two | January 1, 2017

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting period

2 years

Restricted shares | Key management personnel of entity or parent | Share-based Compensation Award, Tranche Two | January 1, 2018

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting period

3 years

Restricted shares | Key management personnel of entity or parent | Share-based Compensation Award, Tranche Two

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting rights, percentage

50.00%

Restricted shares | Key management personnel of entity or parent | Share-based Compensation Award, Tranche One | January 1, 2016

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting period

2 years

Restricted shares | Key management personnel of entity or parent | Share-based Compensation Award, Tranche One | January 1, 2017

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting period

2 years

Restricted shares | Key management personnel of entity or parent | Share-based Compensation Award, Tranche One | January 1, 2018

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting period

2 years

LTIP vesting

Disclosure of terms and conditions of share-based payment arrangement [line items]

Award vesting rights, percentage

50.00%

Share based compensation rese_5

Share based compensation reserve - Valuation Assumptions (Details) - Restricted shares	9 Months Ended
	Sep. 30, 2021$ / shares
January 1, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price	$ 16.72
Exercise price	$ 0
Expected volatility of the share price	22.70%
Dividend yield expected	0.00%
Risk free rate	2.55%
Employee exit rate	14.00%
EBITDA Performance Target Conditions	35.00%
January 1, 2018 | Bottom of range
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share	1 year 6 months
January 1, 2018 | Top of range
Disclosure of terms and conditions of share-based payment arrangement [line items]
Expected life of restricted share	4 years
January 1, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price	$ 20.15
Exercise price	$ 0
Expected life of restricted share	4 years
Expected volatility of the share price	24.00%
Dividend yield expected	0.00%
Risk free rate	1.33%
Employee exit rate	14.00%
EBITDA Performance Target Conditions	35.00%
January 1, 2020
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date price	$ 22.37
Exercise price	$ 0
Expected life of restricted share	4 years
Expected volatility of the share price	24.40%
Dividend yield expected	0.00%
Risk free rate	1.70%
Employee exit rate	27.30%
EBITDA Performance Target Conditions	35.00%

Share based compensation rese_6

Share based compensation reserve - Non-Executive Director Restricted Share Awards (Details) $ / shares in Units, € in Millions	Jun. 30, 2021$ / shares	Jun. 17, 2020$ / sharesshares	Sep. 30, 2021EUR (€)	Sep. 30, 2020EUR (€)	Sep. 30, 2021USD ($)shares	Sep. 30, 2021EUR (€)shares	Sep. 30, 2020EUR (€)
Non-Executive Director
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)	24,759	32,140			24,406	24,406
Liabilities from share-based payment transactions (in shares)		7,734
Restricted shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)					1,861,826	1,861,826
Restricted shares | Non-Executive Director
Disclosure of terms and conditions of share-based payment arrangement [line items]
Other equity instruments granted in share-based payment arrangement, per director | $					$ 100,000
Expense from share-based payment transactions with employees | €			€ 0.2	€ 0.2		€ 0.6	€ 0.5
Shares issued, price per share (in dollars per share) | $ / shares	$ 28.27	$ 21.78

Share based compensation rese_7

Share based compensation reserve - Reserve Summary (Details) - EUR (€) € in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Disclosure of terms and conditions of share-based payment arrangement [line items]
Reserve of share-based payments	€ 8.3
Share based payment charge		€ 5.3
Reserve of share-based payments	3.8
Share based compensation reserve
Disclosure of terms and conditions of share-based payment arrangement [line items]
Reserve of share-based payments	8.3
Reserve of share-based payments	3.8
Share based compensation reserve | Non-Executive Director
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share based payment charge	0.6
Share based compensation reserve | Key Management Personnel Of Entity Or Parent, Reclassification to tax liability
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share based payment charge	(5.6)
Share based compensation reserve | Management Award 2016
Disclosure of terms and conditions of share-based payment arrangement [line items]
Directors and Senior Management share awards charge - January 1, 2018	(0.7)
Share based compensation reserve | January 1, 2018 | Key management personnel of entity or parent
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share based payment charge	0.2
Share based compensation reserve | January 1, 2019 | Key management personnel of entity or parent
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share based payment charge	0.2
Share based compensation reserve | January 1, 2020 | Key management personnel of entity or parent
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share based payment charge	€ 0.8

Share Capital and Capital res_3

Share Capital and Capital reserve - Narrative (Details) $ / shares in Units, € in Millions, $ in Millions

Aug. 05, 2021USD ($)

Jan. 04, 2021$ / sharesshares

Feb. 02, 2020

Jan. 02, 2020

Jan. 02, 2019

Jun. 30, 2021

Sep. 30, 2021EUR (€)

Sep. 30, 2021USD ($)

Sep. 30, 2020$ / shares

Sep. 30, 2021$ / shares

Sep. 29, 2021EUR (€)

Jan. 01, 2021EUR (€)

Dec. 31, 2020EUR (€)

Dec. 31, 2020$ / shares

Disclosure of classes of share capital [line items]

Percentage increase in dividend price

20.00%

20.00%

20.00%

Dividends recognised as distributions to owners per share (in dollars per share)

$ 25.2127

$ 21.7289

Preference shares, dividend payment terms, weighted average share price, minimum term required

10 days

10 days

10 days

Share repurchase programme | $

$ 300

Proceeds from sale or issue of treasury shares

€ 10.5

$ 12.8

Other reserves | €

€ (5.9)

€ (7)

€ 21.7

€ 24.5

Reserve of change in value of forward elements of forward contracts | €

€ 1.1

€ 4.4

€ 0

Purchase of treasury shares | $

$ 500

Ordinary shares | Issued Capital and Capital Reserve

Disclosure of classes of share capital [line items]

Par value per share (in usd per share)

$ 10

$ 10

Ordinary shares | Founder Entities

Disclosure of classes of share capital [line items]

Founder preferred shares annual dividend amount (in shares) | shares

3,875,036

Founder Preferred shares | Issued Capital and Capital Reserve

Disclosure of classes of share capital [line items]

Par value per share (in usd per share)

$ 10

$ 10

Share Capital and Capital res_4

Share Capital and Capital reserve - Schedule (Details) - EUR (€) € in Millions	Sep. 30, 2021	Dec. 31, 2020
Disclosure of classes of share capital [line items]
Total share capital and capital reserve	€ 1,690.2	€ 1,647.5
Listing and share transaction costs	0	(27)
Total net share capital and capital reserve	1,690.2	1,620.5
Ordinary shares
Disclosure of classes of share capital [line items]
Total share capital and capital reserve	1,679.6	1,636.9
Founder Preferred shares
Disclosure of classes of share capital [line items]
Total share capital and capital reserve	€ 10.6	€ 10.6
Issued Capital and Capital Reserve | Ordinary shares
Disclosure of classes of share capital [line items]
Issued and fully paid (in shares)	176,649,255	172,180,897
Issued Capital and Capital Reserve | Founder Preferred shares
Disclosure of classes of share capital [line items]
Issued and fully paid (in shares)	1,500,000	1,500,000

Related parties (Details)

Related parties (Details) - EUR (€) € in Millions	Jan. 04, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Non-Executive Director
Disclosure of transactions between related parties [line items]
Fees and expenses		€ 0.1	€ 0.1	€ 0.3	€ 0.3
Ordinary shares | Founder Entities
Disclosure of transactions between related parties [line items]
Founder preferred shares annual dividend amount (in shares)	3,875,036
Mariposa Capital and TOMS Capital | Affiliate of Founder Entities
Disclosure of transactions between related parties [line items]
Fees and expenses		€ 0.4	€ 0.4	€ 1.2	€ 1.4

Subsequent events after the S_2

Subsequent events after the Statement of Financial Position date (Details) € in Millions, $ in Millions	Aug. 05, 2021USD ($)	Sep. 30, 2021EUR (€)	Jul. 09, 2021EUR (€)	Jun. 24, 2021EUR (€)
Events after Reporting Period [Line Items]
Purchase of treasury shares | $	$ 500
Twenty Twenty-Eight Fixed Rate Senior Secured Notes
Events after Reporting Period [Line Items]
Notional amount | €		€ 750	€ 50	€ 750
Interest rate		2.50%	2.50%

Uncategorized Items - nomd-2021

Label	Element	Value
Treasury shares [member]
Increase (decrease) in number of shares outstanding	ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding	(507,396)